170 results on '"Sara Wells"'
Search Results
2. A mouse model with a frameshift mutation in the nuclear factor I/X (NFIX) gene has phenotypic features of Marshall‐Smith syndrome
- Author
-
Kreepa G. Kooblall, Mark Stevenson, Michelle Stewart, Lachlan Harris, Oressia Zalucki, Hannah Dewhurst, Natalie Butterfield, Houfu Leng, Tertius A. Hough, Da Ma, Bernard Siow, Paul Potter, Roger D. Cox, Stephen D.M. Brown, Nicole Horwood, Benjamin Wright, Helen Lockstone, David Buck, Tonia L. Vincent, Fadil M. Hannan, J.H. Duncan Bassett, Graham R. Williams, Kate E. Lines, Michael Piper, Sara Wells, Lydia Teboul, Raoul C. Hennekam, Rajesh V. Thakker, General Paediatrics, and APH - Quality of Care
- Subjects
Model organisms ,frameshift mutation ,Endocrinology, Diabetes and Metabolism ,FOS: Clinical medicine ,Stem Cells ,NFIX ,Neurosciences ,Gene Expression ,Imaging ,kyphosis ,osteopenia ,brain abnormalities ,Orthopedics and Sports Medicine ,Genetics & Genomics ,Developmental Biology - Abstract
The nuclear factor I/X (NFIX) gene encodes a ubiquitously expressed transcription factor whose mutations lead to two allelic disorders characterized by developmental, skeletal, and neural abnormalities, namely, Malan syndrome (MAL) and Marshall–Smith syndrome (MSS). NFIX mutations associated with MAL mainly cluster in exon 2 and are cleared by nonsense-mediated decay (NMD) leading to NFIX haploinsufficiency, whereas NFIX mutations associated with MSS are clustered in exons 6–10 and escape NMD and result in the production of dominant-negative mutant NFIX proteins. Thus, different NFIX mutations have distinct consequences on NFIX expression. To elucidate the in vivo effects of MSS-associated NFIX exon 7 mutations, we used CRISPR-Cas9 to generate mouse models with exon 7 deletions that comprised: a frameshift deletion of two nucleotides (Nfix Del2); in-frame deletion of 24 nucleotides (Nfix Del24); and deletion of 140 nucleotides (Nfix Del140). Nfix+/Del2, Nfix+/Del24, Nfix+/Del140, NfixDel24/Del24, and NfixDel140/Del140 mice were viable, normal, and fertile, with no skeletal abnormalities, but NfixDel2/Del2 mice had significantly reduced viability (p < 0.002) and died at 2–3 weeks of age. Nfix Del2 was not cleared by NMD, and NfixDel2/Del2 mice, when compared to Nfix+/+ and Nfix+/Del2 mice, had: growth retardation; short stature with kyphosis; reduced skull length; marked porosity of the vertebrae with decreased vertebral and femoral bone mineral content; and reduced caudal vertebrae height and femur length. Plasma biochemistry analysis revealed NfixDel2/Del2 mice to have increased total alkaline phosphatase activity but decreased C-terminal telopeptide and procollagen-type-1-N-terminal propeptide concentrations compared to Nfix+/+ and Nfix+/Del2 mice. NfixDel2/Del2 mice were also found to have enlarged cerebral cortices and ventricular areas but smaller dentate gyrus compared to Nfix+/+ mice. Thus, NfixDel2/Del2 mice provide a model for studying the in vivo effects of NFIX mutants that escape NMD and result in developmental abnormalities of the skeletal and neural tissues that are associated with MSS. © 2023 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.
- Published
- 2023
- Full Text
- View/download PDF
3. Considering Religious Education and Online Pedagogy
- Author
-
Kutter Callaway, Tommy Lister, and Sara Wells
- Abstract
This chapter contends that online pedagogies in the context of Christian theological higher education are most effective when they not only draw upon the best pedagogical theories for online teaching and learning but also when they embody and perform the distinctives of the particular theological tradition into which they are forming students. It begins with an overview of the current state of research taking place in the domain of Universal Design for Learning (UDL). It then considers the important discourse surrounding educational psychology. The chapter then shifts to focus on spiritual formation as a learning outcome that is perhaps unique to religious higher education, which indicates that the best online pedagogies are always already formative, even if they are not explicitly religious. Finally, it concludes by considering how this area of research is related to and can be seen as situated within the area of digital religion studies.
- Published
- 2022
4. Identifying genetic determinants of inflammatory pain in mice using a large-scale gene-targeted screen
- Author
-
Sara Wells, Marc Parisien, Abigail J. D’Souza, Rasneer Sonia Bains, Hamed Haselimashhadi, Mary E. Dickinson, Matthew Mckay, Amelia M. Willett, Christopher S. Ward, Robert Braun, Jeremy Mason, Stephen A. Murray, Emma Peterson, Michayla A. Moore, Damian Smedley, Erin E. Young, Luis Santos, Elissa L. Chesler, Laura C. Anderson, Rachel Urban, Helen Parkinson, Lynette Bower, John R. Seavitt, Dawei Qu, Leslie O. Goodwin, Vivek Kumar, Jason D. Heaney, Subhiksha Srinivasan, Kevin C K Lloyd, Mark E. Harrison, Steve D.M. Brown, Colin McKerlie, Ann M. Flenniken, Jacqueline K. White, Lauryl M. J. Nutter, Ziyue Huang, Jason A. Bubier, Daniel J. Delbarre, Robert P. Bonin, Kyle M. Baumbauer, Alexandr Bezginov, Dave Clary, Igor Vukobradovic, Ann-Marie Mallon, Silvia Mandillo, Luda Diatchenko, Surabi Veeraragavan, Michelle Stewart, Rodney C. Samaco, and Janine M Wotton
- Subjects
Nociception ,Scale (ratio) ,Autism ,Freund's Adjuvant ,Pain ,Comorbidity ,Computational biology ,Biology ,Sensitization ,Mice ,Hargreaves ,IMPC ,Animals ,Single-gene knockout mouse ,Gene ,Pain Measurement ,Mice, Knockout ,Inflammatory pain ,Formalin ,Anesthesiology and Pain Medicine ,Neurology ,Screen ,Complete Freund's adjuvant ,Nocifensive behavior ,Neurology (clinical) ,von Frey - Abstract
Identifying the genetic determinants of pain is a scientific imperative given the magnitude of the global health burden that pain causes. Here, we report a genetic screen for nociception, performed under the auspices of the International Mouse Phenotyping Consortium. A biased set of 110 single-gene knockout mouse strains was screened for 1 or more nociception and hypersensitivity assays, including chemical nociception (formalin) and mechanical and thermal nociception (von Frey filaments and Hargreaves tests, respectively), with or without an inflammatory agent (complete Freund's adjuvant). We identified 13 single-gene knockout strains with altered nocifensive behavior in 1 or more assays. All these novel mouse models are openly available to the scientific community to study gene function. Two of the 13 genes (Gria1 and Htr3a) have been previously reported with nociception-related phenotypes in genetically engineered mouse strains and represent useful benchmarking standards. One of the 13 genes (Cnrip1) is known from human studies to play a role in pain modulation and the knockout mouse reported herein can be used to explore this function further. The remaining 10 genes (Abhd13, Alg6, BC048562, Cgnl1, Cp, Mmp16, Oxa1l, Tecpr2, Trim14, and Trim2) reveal novel pathways involved in nociception and may provide new knowledge to better understand genetic mechanisms of inflammatory pain and to serve as models for therapeutic target validation and drug development.
- Published
- 2021
5. Hypercalcaemic mice harbouring a germline ablation of G-protein subunit alpha-11 have anaemia that is corrected by treatment with erythropoietin
- Author
-
Fadil Hannan, Mark Stevenson, Kreepa Kooblall, Mie Olesen, Marianne Yon, Michelle Stewart, Sara Wells, Bassett J.H. Duncan, Graham Williams, and Rajesh Thakker
- Published
- 2022
6. The AXT914 calcilytic compound increases plasma calcium and PTH in a mouse model for autosomal dominant hypocalcaemia type 1 (ADH1)
- Author
-
Kreepa Kooblall, Fadil Hannan, Mark Stevenson, Kate Lines, Xin Meng, Michelle Stewart, Sara Wells, Jurg Gasser, and Rajesh Thakker
- Published
- 2022
7. Early embryonic lethality in complex I associated p.L104P Nubpl mutant mice
- Author
-
Cheng Cheng, James Cleak, Lan Weiss, Heather Cater, Michelle Stewart, Sara Wells, Rod Carlo Columbres, Alyaa Shmara, C. Alejandra Morato Torres, Faria Zafar, Birgitt Schüle, Jonathan Neumann, Eli Hatchwell, and Virginia Kimonis
- Subjects
Aging ,Knockout ,Neurodegenerative ,NUBPL ,Mouse model ,Mitochondrial Proteins ,Mice ,Genetics ,2.1 Biological and endogenous factors ,Animals ,Pharmacology (medical) ,Aetiology ,Genetics (clinical) ,Genetics & Heredity ,Mice, Knockout ,Parkinson's Disease ,Other Medical and Health Sciences ,Electron Transport Complex I ,Neurosciences ,Complex I deficiency ,General Medicine ,Mitochondria ,Brain Disorders ,Neurological ,Mutation ,Parkinson’s disease ,alpha-Synuclein - Abstract
Background Variants in the mitochondrial complex I assembly factor, NUBPL are associated with a rare cause of complex I deficiency mitochondrial disease. Patients affected by complex I deficiency harboring homozygous NUBPL variants typically have neurological problems including seizures, intellectual disability, and ataxia associated with cerebellar hypoplasia. Thus far only 19 cases have been reported worldwide, and no treatment is available for this rare disease. Methods To investigate the pathogenesis of NUBPL-associated complex I deficiency, and for translational studies, we generated a knock-in mouse harboring a patient-specific variant Nubpl c.311T>C; p. L104P reported in three families. Results Similar to Nubpl global knockout mice, the Nubpl p. L104P homozygous mice are lethal at embryonic day E10.5, suggesting that the Nubpl p. L104P variant is likely a hypomorph allele. Given the recent link between Parkinson’s disease and loss-of-function NUBPL variants, we also explored aging-related behaviors and immunocytochemical changes in Nubpl hemizygous mice and did not find significant behavioral and pathological changes for alpha-synuclein and oxidative stress markers . Conclusion Our data suggest that homozygotes with Nubpl variants, similar to the null mice, are lethal, and heterozygotes are phenotypically and neuropathologically normal. We propose that a tissue-specific knockout strategy is required to establish a mouse model of Nubpl-associated complex I deficiency disorder for future mechanistic and translational studies.
- Published
- 2022
8. Improving biomedical research by automated behaviour monitoring in the animal home cage - action needed for networking
- Author
-
Sabine M, Hölter, Sara, Wells, and Vootele, Voikar
- Subjects
General Veterinary ,Animal Science and Zoology - Abstract
The key goal in biomedical research is a better understanding of disease aetiologies, which ideally results in strategies and recommendations for the prevention of diseases before they arise, and in the development of effective therapies. However, many concerns have been expressed about the reproducibility and the translational validity of preclinical research in animal models to inform clinical trials in humans. It has been proposed that improving internal, external and construct validity of animal studies will lead to improved translatability. Automated behaviour monitoring in the animal’s home cage, which allows for longitudinal assessment of individual trajectories over sufficiently long intervals for (chronic) drug treatment or phenotype progression, is a promising solution to these problems.
- Published
- 2022
9. Perspectives on Cognitive Phenotypes and Models of Vascular Disease
- Author
-
Selen C. Muratoglu, Marc F. Charette, Zorina S. Galis, Adam S. Greenstein, Alan Daugherty, Anne Joutel, Beth A. Kozel, Donna M. Wilcock, Emily C. Collins, Farzaneh A. Sorond, Gareth R. Howell, Hyacinth I. Hyacinth, Kent K.C. Lloyd, Kurt R. Stenmark, Manfred Boehm, Mark L. Kahn, Roderick Corriveau, Sara Wells, Timothy J. Bussey, Stacey J. Sukoff Rizzo, and M. Luisa Iruela-Arispe
- Subjects
Dementia, Vascular ,Reproducibility of Results ,blood pressure ,vascular dementia ,Article ,Mice ,Cognition ,Phenotype ,atrophy ,Animals ,risk factors ,Cognitive Dysfunction ,mutation ,Cardiology and Cardiovascular Medicine - Abstract
Clinical investigations have established that vascular-associated medical conditions are significant risk factors for various kinds of dementia. And yet, we are unable to associate certain types of vascular deficiencies with specific cognitive impairments. The reasons for this are many, not the least of which are that most vascular disorders are multi-factorial and the development of vascular dementia in humans is often a multi-year or multi-decade progression. To better study vascular disease and its underlying causes, the National Heart, Lung, and Blood Institute of the National Institutes of Health has invested considerable resources in the development of animal models that recapitulate various aspects of human vascular disease. Many of these models, mainly in the mouse, are based on genetic mutations, frequently using single-gene mutations to examine the role of specific proteins in vascular function. These models could serve as useful tools for understanding the association of specific vascular signaling pathways with specific neurological and cognitive impairments related to dementia. To advance the state of the vascular dementia field and improve the information sharing between the vascular biology and neurobehavioral research communities, National Heart, Lung, and Blood Institute convened a workshop to bring in scientists from these knowledge domains to discuss the potential utility of establishing a comprehensive phenotypic cognitive assessment of a selected set of existing mouse models, representative of the spectrum of vascular disorders, with particular attention focused on age, sex, and rigor and reproducibility. The workshop highlighted the potential of associating well-characterized vascular disease models, with validated cognitive outcomes, that can be used to link specific vascular signaling pathways with specific cognitive and neurobehavioral deficits.
- Published
- 2022
10. Ap2s1 mutation causes hypercalcaemia in mice and impairs interaction between calcium-sensing receptor and adaptor protein-2
- Author
-
Mark Stevenson, Gemma F. Codner, Rajesh V. Thakker, Michelle Stewart, Sara Wells, Fadil M. Hannan, Kreepa Kooblall, Asha L. Bayliss, Lydia Teboul, Victoria Stokes, and Caroline M Gorvin
- Subjects
AcademicSubjects/SCI01140 ,medicine.medical_specialty ,Cinacalcet ,Hypercalcaemia ,Adaptor Protein Complex sigma Subunits ,Adaptor Protein Complex 2 ,Parathyroid hormone ,030209 endocrinology & metabolism ,Biology ,medicine.disease_cause ,Mice ,03 medical and health sciences ,0302 clinical medicine ,Bone Density ,Internal medicine ,Genetics ,medicine ,Animals ,Humans ,Missense mutation ,Receptor ,Molecular Biology ,Genetics (clinical) ,030304 developmental biology ,Gene Editing ,0303 health sciences ,Mutation ,Signal transducing adaptor protein ,General Medicine ,medicine.disease ,Disease Models, Animal ,Fibroblast Growth Factor-23 ,Phenotype ,Endocrinology ,Hypercalcemia ,Calcium ,General Article ,CRISPR-Cas Systems ,Calcium-sensing receptor ,Receptors, Calcium-Sensing ,medicine.drug - Abstract
Adaptor protein 2 (AP2), a heterotetrameric complex comprising AP2α, AP2β2, AP2μ2 and AP2σ2 subunits, is ubiquitously expressed and involved in endocytosis and trafficking of membrane proteins, such as the calcium-sensing receptor (CaSR), a G-protein coupled receptor that signals via Gα11. Mutations of CaSR, Gα11 and AP2σ2, encoded by AP2S1, cause familial hypocalciuric hypercalcaemia types 1–3 (FHH1–3), respectively. FHH3 patients have heterozygous AP2S1 missense Arg15 mutations (p.Arg15Cys, p.Arg15His or p.Arg15Leu) with hypercalcaemia, which may be marked and symptomatic, and occasional hypophosphataemia and osteomalacia. To further characterize the phenotypic spectrum and calcitropic pathophysiology of FHH3, we used CRISPR/Cas9 genome editing to generate mice harboring the AP2S1 p.Arg15Leu mutation, which causes the most severe FHH3 phenotype. Heterozygous (Ap2s1+/L15) mice were viable, and had marked hypercalcaemia, hypermagnesaemia, hypophosphataemia, and increases in alkaline phosphatase activity and fibroblast growth factor-23. Plasma 1,25-dihydroxyvitamin D was normal, and no alterations in bone mineral density or bone turnover were noted. Homozygous (Ap2s1L15/L15) mice invariably died perinatally. Co-immunoprecipitation studies showed that the AP2S1 p.Arg15Leu mutation impaired protein–protein interactions between AP2σ2 and the other AP2 subunits, and also with the CaSR. Cinacalcet, a CaSR positive allosteric modulator, decreased plasma calcium and parathyroid hormone concentrations in Ap2s1+/L15 mice, but had no effect on the diminished AP2σ2-CaSR interaction in vitro. Thus, our studies have established a mouse model that is representative for FHH3 in humans, and demonstrated that the AP2S1 p.Arg15Leu mutation causes a predominantly calcitropic phenotype, which can be ameliorated by treatment with cinacalcet.
- Published
- 2021
11. A novel knockout mouse for the small EDRK-rich factor 2 (Serf2) showing developmental and other deficits
- Author
-
Elizabeth M. C. Fisher, Michelle Stewart, Lydia Teboul, Toby Collins, Matthew Rickman, Zsombor Szoke-Kovacs, Karen Cleverley, Weaverly Colleen Lee, Joffrey Mianné, Cheryl Maduro, Frances K. Wiseman, Thomas J. Cunningham, Paige Mumford, James Cleak, and Sara Wells
- Subjects
Male ,Amyloid ,Genotype ,Developmental Disabilities ,Context (language use) ,Biology ,Article ,Cell Line ,03 medical and health sciences ,Mice ,0302 clinical medicine ,Genetics ,Animals ,Genetic Predisposition to Disease ,Allele ,Alleles ,Embryonic Stem Cells ,Genetic Association Studies ,030304 developmental biology ,Mice, Knockout ,0303 health sciences ,Age Factors ,Intracellular Signaling Peptides and Proteins ,X-Ray Microtomography ,Embryonic stem cell ,Phenotype ,In vitro ,Cell biology ,Alternative Splicing ,Disease Models, Animal ,Proteotoxicity ,Gene Expression Regulation ,Genetic Loci ,Organ Specificity ,Knockout mouse ,Female ,Genetic Background ,030217 neurology & neurosurgery - Abstract
The small EDRK-rich factor 2 (SERF2) is a highly conserved protein that modifies amyloid fibre assembly in vitro and promotes protein misfolding. However, the role of SERF2 in regulating age-related proteotoxicity remains largely unexplored due to a lack of in vivo models. Here, we report the generation of Serf2 knockout mice using an ES cell targeting approach, with Serf2 knockout alleles being bred onto different defined genetic backgrounds. We highlight phenotyping data from heterozygous Serf2+/− mice, including unexpected male-specific phenotypes in startle response and pre-pulse inhibition. We report embryonic lethality in Serf2−/− null animals when bred onto a C57BL/6 N background. However, homozygous null animals were viable on a mixed genetic background and, remarkably, developed without obvious abnormalities. The Serf2 knockout mice provide a powerful tool to further investigate the role of SERF2 protein in previously unexplored pathophysiological pathways in the context of a whole organism.
- Published
- 2021
12. Investigating audible and ultrasonic noise in modern animal facilities
- Author
-
Andrew Parker, Liane Hobson, Rasneer Bains, Sara Wells, and Michael Bowl
- Subjects
Mice ,General Immunology and Microbiology ,Animals ,Humans ,Ultrasonics ,General Medicine ,Acoustics ,General Pharmacology, Toxicology and Pharmaceutics ,Noise ,General Biochemistry, Genetics and Molecular Biology - Abstract
Background: The environmental housing conditions of laboratory animals are important for both welfare and reliable, reproducible data. Guidelines currently exist for factors such as lighting cycles, temperature, humidity, and noise, however, for the latter the current guidelines may overlook important details. In the case of the most common laboratory species, the mouse, the range of frequencies they can hear is far higher than that of humans. The current guidelines briefly mention that ultrasonic (>20 kHz) frequencies can adversely affect mice, and that the acoustic environment should be checked, though no recommendations are provided relating to acceptable levels of ultrasonic noise. Methods: To investigate the ultrasonic environment in a large mouse breeding facility (the Mary Lyon Centre at MRC Harwell), we compared two systems, the Hottinger Bruel and Kjaer PULSE sound analyser, and an Avisoft Bioacoustics system. Potential noise sources were selected; we used the PULSE system to undertake real-time Fourier analysis of noise up to 100 kHz, and the Avisoft system to record noise up to 125 kHz for later analysis. The microphones from both systems were positioned consistently at the same distance from the source and environmental conditions were identical. In order to investigate our result further, a third system, the AudioMoth (Open Acoustic Devices), was also used for recording. We used DeepSqueak software for most of the recording analysis and, in some cases, we also undertook further spectral analysis using RX8 (iZotope, USA). Results: We found that both systems can detect a range of ultrasonic noise sources, and here discuss the benefits and limitations of each approach. Conclusions: We conclude that measuring the acoustic environment of animal facilities, including ultrasonic frequencies that may adversely affect the animals housed, will contribute to minimising disruption to animal welfare and perturbations in scientific research.
- Published
- 2022
13. Gadd45g is required for timely Sry expression independently of RSPO1 activity
- Author
-
Nick Warr, Pam Siggers, Joel May, Nicolas Chalon, Madeleine Pope, Sara Wells, Marie-Christine Chaboissier, Andy Greenfield, MRC Harwell Institute [UK], Institut de Biologie Valrose (IBV), Université Nice Sophia Antipolis (1965 - 2019) (UNS), COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Côte d'Azur (UCA), and Chaboissier, Marie-Christine
- Subjects
Male ,Embryology ,endocrine system ,Sex Differentiation ,Sry gene ,[SDV]Life Sciences [q-bio] ,Mice ,Endocrinology ,Testis ,Animals ,Rspo1 signalling ,Gonads ,Wnt Signaling Pathway ,Mammals ,Ovary ,Obstetrics and Gynecology ,Gene Expression Regulation, Developmental ,SOX9 Transcription Factor ,Cell Biology ,Sex Determination Processes ,Sex reversal ,Sex-Determining Region Y Protein ,[SDV] Life Sciences [q-bio] ,Reproductive Medicine ,Female ,Thrombospondins - Abstract
Sex determination in mammals is controlled by the dominance of either pro-testis (SRY-SOX9-FGF9) or pro-ovary (RSPO1-WNT4-FOXL2) genetic pathways during early gonad development in XY and XX embryos, respectively. We have previously shown that early, robust expression of mouse Sry is dependent on the nuclear protein GADD45g. In the absence of GADD45g, XY gonadal sex reversal occurs, associated with a major reduction of Sry levels at 11.5 dpc. Here, we probe the relationship between Gadd45g and Sry further, using gain- and loss-of-function genetics. First, we show that transgenic Gadd45g overexpression can elevate Sry expression levels at 11.5 dpc in the B6.YPOS model of sex reversal, resulting in phenotypic rescue. We then show that the zygosity of pro-ovarian Rspo1 is critical for the degree of gonadal sex reversal observed in both B6.YPOS and Gadd45g-deficient XY gonads, in contrast to that of Foxl2. Phenotypic rescue of sex reversal is observed in XY gonads lacking both Gadd45g and Rspo1, but this is not associated with rescue of Sry expression levels at 11.5 dpc. Instead, Sox9 levels are rescued by around 12.5 dpc. We conclude that Gadd45g is absolutely required for timely expression of Sry in XY gonads, independently of RSPO1-mediated WNT signalling, and discuss these data in light of our understanding of antagonistic interactions between the pro-testis and pro-ovary pathways.
- Published
- 2022
14. Variability in Genome Editing Outcomes: Challenges for Research Reproducibility and Clinical Safety
- Author
-
Lydia Teboul, Guillaume Pavlovic, Sara Wells, Yann Herault, Waseem Qasim, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), and Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Strasbourg (UNISTRA)
- Subjects
Animal Experimentation ,Computer science ,[SDV]Life Sciences [q-bio] ,Gene Expression ,Context (language use) ,Molecular evidence ,Computational biology ,Review ,clinical safety ,Risk Assessment ,medical research ,Translational Research, Biomedical ,03 medical and health sciences ,0302 clinical medicine ,Genome editing ,Drug Discovery ,Genetics ,research reproducibility ,CRISPR ,Animals ,Humans ,gene delivery ,Molecular Biology ,CRISPR/Cas9 ,ComputingMilieux_MISCELLANEOUS ,030304 developmental biology ,Pharmacology ,Gene Editing ,0303 health sciences ,Clinical Studies as Topic ,Gene Transfer Techniques ,Reproducibility of Results ,Genetic Therapy ,Medical research ,gene therapy ,3. Good health ,Organ Specificity ,030220 oncology & carcinogenesis ,Molecular Medicine ,Clinical safety ,CRISPR-Cas Systems ,Functional genomics ,functional genomics - Abstract
Genome editing tools have already revolutionized biomedical research and are also expected to have an important impact in the clinic. However, their extensive use in research has revealed much unpredictability, both off and on target, in the outcome of their application. We discuss the challenges associated with this unpredictability, both for research and in the clinic. For the former, an extensive validation of the model is essential. For the latter, potential unpredicted activity does not preclude the use of these tools but requires that molecular evidence to underpin the relevant risk:benefit evaluation is available. Safe and successful clinical application will also depend on the mode of delivery and the cellular context., Graphical Abstract, Genome editing tools have already revolutionized biomedical research and will have a major impact in the clinic. However, the unpredictability of genome editing outcomes raises the question of its safety for human therapy. This article reviews molecular evidences both in animals models and human and their implications for risk:benefit evaluation.
- Published
- 2020
15. Fam151b, the mouse homologue of C.elegans menorin gene, is essential for retinal function
- Author
-
Luis Sanchez-Pulido, Lisa McKie, Sara Wells, Margaret A. Keighren, Sally H. Cross, Sharon Clementson-Mobbs, Ian J. Jackson, and Amy S. Findlay
- Subjects
0301 basic medicine ,Retinal degeneration ,Models, Molecular ,genetic structures ,Protein Conformation ,Mutant ,lcsh:Medicine ,Cell Count ,Biology ,medicine.disease_cause ,Article ,Retina ,03 medical and health sciences ,chemistry.chemical_compound ,Gene Knockout Techniques ,Mice ,0302 clinical medicine ,Sequence Homology, Nucleic Acid ,medicine ,Genetics ,Animals ,Humans ,Amino Acid Sequence ,Caenorhabditis elegans Proteins ,lcsh:Science ,Gene ,Eye diseases ,Mutation ,Multidisciplinary ,lcsh:R ,Membrane Proteins ,Retinal ,medicine.disease ,Phenotype ,eye diseases ,Cell biology ,030104 developmental biology ,medicine.anatomical_structure ,chemistry ,lcsh:Q ,sense organs ,030217 neurology & neurosurgery ,Photoreceptor Cells, Vertebrate - Abstract
Fam151b is a mammalian homologue of the C. elegans menorin gene, which is involved in neuronal branching. The International Mouse Phenotyping Consortium (IMPC) aims to knock out every gene in the mouse and comprehensively phenotype the mutant animals. This project identified Fam151b homozygous knock-out mice as having retinal degeneration. We show they have no photoreceptor function from eye opening, as demonstrated by a lack of electroretinograph (ERG) response. Histological analysis shows that during development of the eye the correct number of cells are produced and that the layers of the retina differentiate normally. However, after eye opening at P14, Fam151b mutant eyes exhibit signs of retinal stress and rapidly lose photoreceptor cells. We have mutated the second mammalian menorin homologue, Fam151a, and homozygous mutant mice have no discernible phenotype. Sequence analysis indicates that the FAM151 proteins are members of the PLC-like phosphodiesterase superfamily. However, the substrates and function of the proteins remains unknown.
- Published
- 2020
16. Neuroplastin genetically interacts with Cadherin 23 and the encoded isoform Np55 is sufficient for cochlear hair cell function and hearing
- Author
-
Sherylanne Newton, Fanbo Kong, Adam J. Carlton, Carlos Aguilar, Andrew Parker, Gemma F. Codner, Lydia Teboul, Sara Wells, Steve D. M. Brown, Walter Marcotti, and Michael R. Bowl
- Subjects
Mice, Knockout ,Cancer Research ,Hair Cells, Auditory, Inner ,Membrane Glycoproteins ,Cadherins ,Mice ,Plasma Membrane Calcium-Transporting ATPases ,Hearing ,Loss of Function Mutation ,otorhinolaryngologic diseases ,Genetics ,Animals ,Protein Isoforms ,sense organs ,Molecular Biology ,Genetics (clinical) ,Ecology, Evolution, Behavior and Systematics - Abstract
Mammalian hearing involves the mechanoelectrical transduction (MET) of sound-induced fluid waves in the cochlea. Essential to this process are the specialised sensory cochlear cells, the inner (IHCs) and outer hair cells (OHCs). While genetic hearing loss is highly heterogeneous, understanding the requirement of each gene will lead to a better understanding of the molecular basis of hearing and also to therapeutic opportunities for deafness. The Neuroplastin (Nptn) gene, which encodes two protein isoforms Np55 and Np65, is required for hearing, and homozygous loss-of-function mutations that affect both isoforms lead to profound deafness in mice. Here we have utilised several distinct mouse models to elaborate upon the spatial, temporal, and functional requirement of Nptn for hearing. While we demonstrate that both Np55 and Np65 are present in cochlear cells, characterisation of a Np65-specific mouse knockout shows normal hearing thresholds indicating that Np65 is functionally redundant for hearing. In contrast, we find that Nptn-knockout mice have significantly reduced maximal MET currents and MET channel open probabilities in mature OHCs, with both OHCs and IHCs also failing to develop fully mature basolateral currents. Furthermore, comparing the hearing thresholds and IHC synapse structure of Nptn-knockout mice with those of mice that lack Nptn only in IHCs and OHCs shows that the majority of the auditory deficit is explained by hair cell dysfunction, with abnormal afferent synapses contributing only a small proportion of the hearing loss. Finally, we show that continued expression of Neuroplastin in OHCs of adult mice is required for membrane localisation of Plasma Membrane Ca2+ ATPase 2 (PMCA2), which is essential for hearing function. Moreover, Nptn haploinsufficiency phenocopies Atp2b2 (encodes PMCA2) mutations, with heterozygous Nptn-knockout mice exhibiting hearing loss through genetic interaction with the Cdh23ahl allele. Together, our findings provide further insight to the functional requirement of Neuroplastin for mammalian hearing.
- Published
- 2022
17. Introduction to Mammalian Genome Special Issue: Mammalian Genetic Resources
- Author
-
Steve D. M. Brown, Joseph H. Nadeau, Sara Wells, Ann-Marie Mallon, Lydia Teboul, Christopher K. Tuggle, and Lawrence B. Schook
- Subjects
Mammals ,Genome ,Genetics ,Animals - Published
- 2022
18. Mendelian gene identification through mouse embryo viability screening
- Author
-
Pilar, Cacheiro, Carl Henrik, Westerberg, Jesse, Mager, Mary E, Dickinson, Lauryl M J, Nutter, Violeta, Muñoz-Fuentes, Chih-Wei, Hsu, Ignatia B, Van den Veyver, Ann M, Flenniken, Colin, McKerlie, Stephen A, Murray, Lydia, Teboul, Jason D, Heaney, K C Kent, Lloyd, Louise, Lanoue, Robert E, Braun, Jacqueline K, White, Amie K, Creighton, Valerie, Laurin, Ruolin, Guo, Dawei, Qu, Sara, Wells, James, Cleak, Rosie, Bunton-Stasyshyn, Michelle, Stewart, Jackie, Harrisson, Jeremy, Mason, Hamed, Haseli Mashhadi, Helen, Parkinson, Ann-Marie, Mallon, and Magdalena, Zarowiecki
- Subjects
Mice, Knockout ,Homozygote ,Embryo, Mammalian ,Mice ,Phenotype ,Pregnancy ,Genetics ,Molecular Medicine ,Animals ,Humans ,Female ,Genes, Lethal ,Molecular Biology ,Genetics (clinical) - Abstract
BackgroundThe diagnostic rate of Mendelian disorders in sequencing studies continues to increase, along with the pace of novel disease gene discovery. However, variant interpretation in novel genes not currently associated with disease is particularly challenging and strategies combining gene functional evidence with approaches that evaluate the phenotypic similarities between patients and model organisms have proven successful. A full spectrum of intolerance to loss-of-function variation has been previously described, providing evidence that gene essentiality should not be considered as a simple and fixed binary property.MethodsHere we further dissected this spectrum by assessing the embryonic stage at which homozygous loss-of-function results in lethality in mice from the International Mouse Phenotyping Consortium, classifying the set of lethal genes into one of three windows of lethality: early, mid, or late gestation lethal. We studied the correlation between these windows of lethality and various gene features including expression across development, paralogy and constraint metrics together with human disease phenotypes. We explored a gene similarity approach for novel gene discovery and investigated unsolved cases from the 100,000 Genomes Project.ResultsWe found that genes in the early gestation lethal category have distinct characteristics and are enriched for genes linked with recessive forms of inherited metabolic disease. We identified several genes sharing multiple features with known biallelic forms of inborn errors of the metabolism and found signs of enrichment of biallelic predicted pathogenic variants among early gestation lethal genes in patients recruited under this disease category. We highlight two novel gene candidates with phenotypic overlap between the patients and the mouse knockouts.ConclusionsInformation on the developmental period at which embryonic lethality occurs in the knockout mouse may be used for novel disease gene discovery that helps to prioritise variants in unsolved rare disease cases.
- Published
- 2022
19. Neuroplastin genetically interacts with Cadherin 23 and the encoded isoform Np55 is sufficient for cochlear hair cell function and hearing
- Author
-
Carlos A. Aguilar, Michael R. Bowl, Adam J Carlton, Steve D.M. Brown, Sara Wells, Fanbo Kong, Lydia Teboul, Andrew Parker, Walter Marcotti, Gemma F. Codner, and Sherylanne Newton
- Subjects
Phenocopy ,Gene isoform ,Hearing loss ,Biology ,Cell biology ,medicine.anatomical_structure ,ATP2B2 ,otorhinolaryngologic diseases ,medicine ,Hair cell ,medicine.symptom ,Haploinsufficiency ,Neuroplastin ,Cochlea - Abstract
Mammalian hearing involves the mechanoelectrical transduction (MET) of sound-induced fluid waves in the cochlea. Essential to this process are the specialised sensory cochlear cells, the inner (IHCs) and outer hair cells (OHCs). While genetic hearing loss is highly heterogeneous, understanding the requirement of each gene will lead to a better understanding of the molecular basis of hearing and also to therapeutic opportunities for deafness. The Neuroplastin (Nptn) gene, which encodes two protein isoforms Np55 and Np65, is required for hearing, and homozygous loss-of-function mutations that affect both isoforms lead to profound deafness in mice. Here we have utilised several distinct mouse models to elaborate upon the spatial, temporal, and functional requirement of Nptn for hearing. While we demonstrate that both Np55 and Np65 are present in cochlear cells, characterisation of a Np65-specific mouse knockout shows normal hearing thresholds indicating that Np65 is functionally redundant for hearing. In contrast, we find that Nptn-knockout mice have significantly reduced maximal MET currents and MET channel open probabilities in mature OHCs, with both OHCs and IHCs also failing to develop fully mature basolateral currents. Furthermore, comparing the hearing thresholds and IHC synapse structure of Nptn-knockout mice with those of mice that lack Nptn only in IHCs and OHCs shows that the majority of the auditory deficit is explained by hair cell dysfunction, with abnormal afferent synapses contributing only a small proportion of the hearing loss. Finally, we show that continued expression of NEUROPLASTIN in OHCs of adult mice is required for membrane localisation of Plasma Membrane Ca2+ ATPase 2 (PMCA2), which is essential for hearing function. Moreover, Nptn haploinsufficiency phenocopies Atp2b2 (encodes PMCA2) mutations, with heterozygous Nptn-knockout mice exhibiting hearing loss through genetic interaction with the Cdh23ahl allele. Together, our findings provide further insight to the functional requirement of Neuroplastin for mammalian hearing.Author SummarySensorineural hearing loss, caused by problems with sensory cells in the cochlea or the auditory nerve, is the most common type of hearing loss. Mutations in Neuroplastin have already been implicated in deafness in mice. We have used mutant mouse models to investigate where Neuroplastin is expressed in the cochlea and its function. When mice do not express a functioning copy of Neuroplastin they have disruptions to the primary sensory synapse. We show that although synaptic disruption contributes to the loss of hearing function it is not the primary cause. Instead, continued expression of Neuroplastin is needed to maintain the localisation of Plasma Membrane Ca2+ ATPase 2 channels which help regulate calcium flow. We have also shown that two types of NEUROPLASTIN protein (isoforms) are both expressed within the cochlea, although only one of these isoforms needs to be expressed for normal hearing. Finally, we also demonstrate that the hearing loss caused by the absence of Neuroplastin is made worse when combined with a common mutation within a gene called Cadherin 23 (Cdh23ahl). This is an important finding as although there are currently no human patients with an identified NEUROPLASTIN mutation, it may be involved in human deafness in combination with other mutations.
- Published
- 2021
20. Nuclear factor I/X (NFIX) regulates the transcriptional activity of the cellular retinoic acid binding protein 2 (CRABP2) promoter and alters CRABP2 expression in Marshall-Smith Syndrome (MSS) patients
- Author
-
Kate E Lines, Mark Stevenson, Lydia Teboul, Sara Wells, Michelle Stewart, Kreepa Kooblall, Rajesh Thakker, and Raoul C.M. Hennekam
- Subjects
Cellular Retinoic Acid Binding Protein ,Transcriptional activity ,Marshall–Smith syndrome ,Nuclear factor I ,biology ,Chemistry ,medicine ,biology.protein ,medicine.disease ,NFIX ,Cell biology - Published
- 2021
21. The production of 4,182 mouse lines identifies experimental and biological variables impacting Cas9-mediated mutant mouse line production
- Author
-
Elif F. Acar, Luis Santos, Graham Duddy, Adam Caulder, Yann Herault, Joshua A. Wood, Jing Zhao, John R. Seavitt, Masaru Tamura, Martin Hrabĕ de Angelis, Gemma F. Codner, Helen Parkinson, Marie-Christine Birling, Lauryl M. J. Nutter, Jason D. Heaney, Radislav Sedlacek, Brandon J. Willis, Susan Marschall, Kevin A. Peterson, Marina Gertsenstein, Alba Gomez-Segura, Allan Bradley, Je Kyung Seong, Lydia Teboul, Kevin C K Lloyd, Fabio Mammano, Jacqueline K. White, Mary E. Dickinson, Francesco Chiani, Matthew Mackenzie, Robert Braun, Isabel Lorenzo, Colin McKerlie, Wolfgang Wurst, Edward Ryder, Cunxiang Ju, Denise G. Lanza, Ruairidh King, Alessia Gambadoro, Ho Lee, Zhiwei Liu, Ramiro Ramirez-Solis, Ann-Marie Mallon, William C. Skarnes, Xiang Gao, Stephen A. Murray, Francesco J. DeMayo, Lauri G. Lintott, Terrence F. Meehan, Fei Zhou, Hannah Wardle-Jones, Shinya Ayabe, Mark T. Ruhe, Atsushi Yoshiki, Brendan Doe, Peter Matthews, Sara Wells, Hillary Elrick, Claudia Seisenberger, David J. Adams, Jie Zhang, Damien Smedley, Petr Kasparek, Daekee Lee, and Leslie O. Goodwin
- Subjects
Genetics ,Mutant ,Null (mathematics) ,Knockout mouse ,Allele ,Biology ,Null allele ,Genome ,Gene ,Germline - Abstract
The International Mouse Phenotyping Consortium (IMPC) is generating and phenotyping null mutations for every protein-coding gene in the mouse1,2. The IMPC now uses Cas9, a programmable RNA-guided nuclease that has revolutionized mouse genome editing3 and increased capacity and flexibility to efficiently generate null alleles in the C57BL/6N strain. In addition to being a valuable novel and accessible research resource, the production of >3,300 knockout mouse lines using comparable protocols provides a rich dataset to analyze experimental and biological variables affecting in vivo null allele engineering with Cas9. Mouse line production has two critical steps – generation of founders with the desired allele and germline transmission (GLT) of that allele from founders to offspring. Our analysis identified that whether a gene is essential for viability was the primary factor influencing successful production of null alleles. Collectively, our findings provide best practice recommendations for generating null alleles in mice using Cas9; these recommendations may be applicable to other allele types and species.
- Published
- 2021
22. Nonhuman primates' tissue banks: resources for all model organism research
- Author
-
Claire Witham and Sara Wells
- Subjects
Primates ,ved/biology ,ved/biology.organism_classification_rank.species ,Computational biology ,Tissue Banks ,Biology ,Biobank ,Human genetics ,Article ,Tissue bank ,Genetics ,Animals ,Model organism ,Ex vivo - Abstract
Biobanks containing tissue and other biological samples from many model organisms provide easy and faster access to ex vivo resources for a wide-range of research programmes. For all laboratory animals, collecting and preserving tissue at post-mortem is an effective way of maximising the benefits of individual animals and potentially reducing the numbers required for experimentation in the future. For primate tissues, biobanks represent the scarcest of these resources but quite possibly those most valuable for preclinical and translation studies.
- Published
- 2021
23. INFRAFRONTIER quality principles in systemic phenotyping
- Author
-
Hilke Ehlich, Reetta Vuolteenaho, Michael Raess, Vasileios Ntafis, Ana Zarubica, Bernard Malissen, Dimitris L. Kontoyiannis, Mohammed Selloum, Tania Sorg, Ann M Flenniken, Martin Hrabě de Angelis, Claudia Stoeger, Yann Herault, Isabelle Goncalves Da Cruz, George Kollias, Sarka Suchanova, Heather Cater, Reetta Hinttala, Radislav Sedlacek, Sara Wells, Colin McKerlie, Anne-Marie Mura, Steve D.M. Brown, Jan Rozman, MRC Harwell Institute [UK], Lunenfeld-Tanenbaum Research Institute [Toronto, Canada], Institut Clinique de la Souris (ICS), Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Centre d'Immunophénomique (CIPHE), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Alexander Fleming Biomedical Sciences Research Center, Partenaires INRAE, Helmholtz-Zentrum München (HZM), Institute of Molecular Genetics of the Czech Academy of Sciences (IMG / CAS), Czech Academy of Sciences [Prague] (CAS), University of Oulu, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Strasbourg (UNISTRA), German Center for Diabetes Research - Deutsches Zentrum für Diabetesforschung [Neuherberg] (DZD), Technische Universität München [München] (TUM), The Hospital for sick children [Toronto] (SickKids), University of Toronto, Technische Universität Munchen - Université Technique de Munich [Munich, Allemagne] (TUM), INFRAFRONTIER GmbH [Neuherberg], Biomedical Sciences Research Centre Alexander Fleming [Vari, Greece] (BSRC), and Helmholtz Zentrum München = German Research Center for Environmental Health
- Subjects
Service (systems architecture) ,media_common.quotation_subject ,[SDV]Life Sciences [q-bio] ,Interoperability ,Context (language use) ,Biology ,03 medical and health sciences ,Preclinical research ,Mice ,0302 clinical medicine ,Genetics ,Animals ,Quality (business) ,030304 developmental biology ,media_common ,Mammals ,0303 health sciences ,[SDV.GEN]Life Sciences [q-bio]/Genetics ,Genome ,European research ,[SDV.BA]Life Sciences [q-bio]/Animal biology ,Reproducibility of Results ,Internal quality ,Disease Models, Animal ,Risk analysis (engineering) ,Key (cryptography) ,030217 neurology & neurosurgery - Abstract
Improving reproducibility and replicability in preclinical research is a widely discussed and pertinent topic, especially regarding ethical responsibility in animal research. INFRAFRONTIER, the European Research Infrastructure for the generation, phenotyping, archiving, and distribution of model mammalian genomes, is addressing this issue by developing internal quality principles for its different service areas, that provides a quality framework for its operational activities. This article introduces the INFRAFRONTIER Quality Principles in Systemic Phenotyping of genetically altered mouse models. A total of 11 key principles are included, ranging from general requirements for compliance with guidelines on animal testing, to the need for well-trained personnel and more specific standards such as the exchange of reference lines. Recently established requirements such as the provision of FAIR (Findable, Accessible, Interoperable, Reusable) data are also addressed. For each quality principle, we have outlined the specific context, requirements, further recommendations, and key references.
- Published
- 2021
24. Beyond MRI: on the scientific value of combining non-human primate neuroimaging with metadata
- Author
-
Suliann Ben Hamed, Colline Poirier, Sara Wells, Jeffrey Rogers, Andrew S. Fox, Hugo Merchant, Pamela Garcia-Saldivar, Adrien Meguerditchian, Sze Chai Kwok, Laboratoire de psychologie cognitive (LPC), Centre National de la Recherche Scientifique (CNRS)-Aix Marseille Université (AMU), Institute of Language, Communication and the Brain (ILCB), Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS), Station de primatologie (SP), Centre National de la Recherche Scientifique (CNRS), and ANR-16-CONV-0002,ILCB,ILCB: Institute of Language Communication and the Brain(2016)
- Subjects
Big Data ,Primates ,Genotype ,Computer science ,Physiology ,Cognitive Neuroscience ,Big data ,Neuroimaging ,050105 experimental psychology ,GeneralLiterature_MISCELLANEOUS ,Article ,lcsh:RC321-571 ,03 medical and health sciences ,[SCCO]Cognitive science ,0302 clinical medicine ,Magnetic resonance imaging ,Genetics ,Animals ,0501 psychology and cognitive sciences ,Behaviour ,lcsh:Neurosciences. Biological psychiatry. Neuropsychiatry ,Phylogeny ,Cognitive science ,Metadata ,Non human primate ,Behavior, Animal ,[SDV.NEU.PC]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Psychology and behavior ,business.industry ,Information Dissemination ,[SCCO.NEUR]Cognitive science/Neuroscience ,05 social sciences ,food and beverages ,BIDS ,Phylogenetics ,Neurology ,business ,030217 neurology & neurosurgery - Abstract
Highlights • Data sharing of primate neuroimaging offers new opportunities. • The potential of metadata to enrich primate neuroimaging is described. • Illustration of how meta-data can be shared in the BIDS format is provided., Sharing and pooling large amounts of non-human primate neuroimaging data offer new exciting opportunities to understand the primate brain. The potential of big data in non-human primate neuroimaging could however be tremendously enhanced by combining such neuroimaging data with other types of information. Here we describe metadata that have been identified as particularly valuable by the non-human primate neuroimaging community, including behavioural, genetic, physiological and phylogenetic data.
- Published
- 2021
25. LAMA: automated image analysis for the developmental phenotyping of mouse embryos
- Author
-
Lydia Teboul, James M. Brown, Neil R. Horner, Shanmugasundaram Venkataraman, Steve D.M. Brown, Henrik Westerberg, Ramón Casero, Ann-Marie Mallon, Matthijs C. van Eede, Sara Wells, Michael D. Wong, Sara Johnson, R. Mark Henkelman, and Chris Armit
- Subjects
G740 Computer Vision ,Automated ,Micro-CT ,Mouse ,Computational biology ,Biology ,Imaging data ,Imaging modalities ,03 medical and health sciences ,Mice ,0302 clinical medicine ,Techniques and Resources ,Imaging, Three-Dimensional ,Control data ,Image Processing, Computer-Assisted ,Animals ,Statistical analysis ,Segmentation ,Molecular Biology ,C141 Developmental Biology ,030304 developmental biology ,Mice, Knockout ,0303 health sciences ,Computational ,Embryo ,G400 Computer Science ,Embryo, Mammalian ,Pipeline (software) ,Mice, Inbred C57BL ,ComputingMethodologies_PATTERNRECOGNITION ,Phenotype ,Phenotyping ,Sample number ,Female ,030217 neurology & neurosurgery ,Software ,Developmental Biology - Abstract
Advanced 3D imaging modalities, such as micro-computed tomography (micro-CT), have been incorporated into the high-throughput embryo pipeline of the International Mouse Phenotyping Consortium (IMPC). This project generates large volumes of raw data that cannot be immediately exploited without significant resources of personnel and expertise. Thus, rapid automated annotation is crucial to ensure that 3D imaging data can be integrated with other multi-dimensional phenotyping data. We present an automated computational mouse embryo phenotyping pipeline that harnesses the large amount of wild-type control data available in the IMPC embryo pipeline in order to address issues of low mutant sample number as well as incomplete penetrance and variable expressivity. We also investigate the effect of developmental substage on automated phenotyping results. Designed primarily for developmental biologists, our software performs image pre-processing, registration, statistical analysis and segmentation of embryo images. We also present a novel anatomical E14.5 embryo atlas average and, using it with LAMA, show that we can uncover known and novel dysmorphology from two IMPC knockout lines., Summary: Introducing an easy-to-use automated anatomical phenotyping pipeline for mouse embryos along with a highly-detailed anatomical E14.5 atlas.
- Published
- 2021
26. Mouse mutant phenotyping at scale reveals novel genes controlling bone mineral density
- Author
-
Paul Flicek, Raffaele Teperino, Lydia Teboul, Thomas Werner, Marie-France Champy, Christopher J. Lelliott, Graham R. Williams, Jacqueline K. White, Gregor Miller, Mary E. Dickinson, Ann M Flenniken, Radislav Sedlacek, Martin Hrabé de Angelis, John R. Seavitt, Peter I. Croucher, Maria del Mar Muniz Moreno, Sara Wells, Jan Rozman, Terrence F. Meehan, Kristian F Odfalk, Juan Gallegos, J. H. Duncan Bassett, Mohammed Selloum, John G. Logan, Sylvie Jacquot, Elena J. Ghirardello, Robert Braun, Frantisek Spoutil, Kevin C K Lloyd, Lore Becker, Stephen A. Murray, Jan Prochazka, Elif F. Acar, Taylor S Vales, Michelle Simon, Helmut Fuchs, Nadine Spielmann, Mark Griffiths, Piia Keskivali-Bond, Valerie Gailus-Durner, Tania Sorg, Christine Schütt, Jeremy Mason, Helen Parkinson, Karen L. Svenson, Abdel Ayadi, Anna L Swan, Jason D. Heaney, Colin McKerlie, Wolfgang Wurst, Ann-Marie Mallon, Heather Cater, Stefanie Leuchtenberger, Harald Grallert, Steve D.M. Brown, Stefan Brandmaier, Yann Herault, Philipp Mayer-Kuckuk, Corey L. Reynolds, Ala Moshiri, Robert Brommage, Derek D. Cissell, Lauryl M J Nutter, Connor Lally, MRC Harwell Institute [UK], German Research Center for Environmental Health - Helmholtz Center München (GmbH), German Center for Diabetes Research - Deutsches Zentrum für Diabetesforschung [Neuherberg] (DZD), Institute of Molecular Genetics of the Czech Academy of Sciences (IMG / CAS), Czech Academy of Sciences [Prague] (CAS), Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Helmholtz-Zentrum München (HZM), The Wellcome Trust Sanger Institute [Cambridge], University of Michigan [Ann Arbor], University of Michigan System, University of California [Davis] (UC Davis), University of California, Baylor College of Medicine (BCM), Baylor University, European Molecular Biology Laboratory [Hinxton], University of Toronto, University of Manitoba [Winnipeg], Lunenfeld-Tanenbaum Research Institute [Toronto, Canada], French National Infrastructure for Mouse Phenogenomics (PHENOMIN), The Jackson Laboratory [Bar Harbor] (JAX), European Bioinformatics Institute [Hinxton] (EMBL-EBI), EMBL Heidelberg, Imperial College London, Technische Universität Munchen - Université Technique de Munich [Munich, Allemagne] (TUM), Deutsches Zentrum für Neurodegenerative Erkrankungen [Ulm] (DZNE), German Research Center for Neurodegenerative Diseases - Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Munich Cluster for systems neurology [Munich] (SyNergy), Technische Universität Munchen - Université Technique de Munich [Munich, Allemagne] (TUM)-Ludwig-Maximilians-Universität München (LMU), Garvan Institute of Medical Research [Sydney, Australia], St. Vincent’s Clinical School [Sydney, Australia], UNSW Faculty of Medicine [Sydney], University of New South Wales [Sydney] (UNSW)-University of New South Wales [Sydney] (UNSW), Université de Nouvelle-Galles du Sud - UNSW [Sydney, Australia], Mundlos, Stefan, Wellcome Trust, Commission of the European Communities, European Commission, Herault, Yann, Helmholtz Zentrum München = German Research Center for Environmental Health, University of California (UC), Garvan Institute of medical research, Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Strasbourg (UNISTRA), Technische Universität München [München] (TUM), Technische Universität München [München] (TUM)-Ludwig-Maximilians-Universität München (LMU), Swan, Anna L [0000-0003-1810-3756], Rozman, Jan [0000-0002-8035-8904], Del Mar Muñiz Moreno, Maria [0000-0002-2662-890X], Leuchtenberger, Stefanie [0000-0003-2475-0810], Brommage, Robert [0000-0002-9947-3822], Grallert, Harald [0000-0002-6876-9655], Werner, Thomas [0000-0003-0402-4539], Teperino, Raffaele [0000-0001-8815-1409], Becker, Lore [0000-0002-6890-4984], Miller, Gregor [0000-0002-4281-4905], Seavitt, John R [0000-0003-3209-3187], Cissell, Derek D [0000-0002-6450-422X], Acar, Elif F [0000-0003-2908-7691], Lelliott, Christopher J [0000-0001-8087-4530], Braun, Robert E [0000-0003-3856-9465], Cater, Heather [0000-0002-8696-6070], Flicek, Paul [0000-0002-3897-7955], Ghirardello, Elena J [0000-0002-1100-9217], Heaney, Jason D [0000-0001-8475-8828], Lally, Connor [0000-0002-3801-1966], Logan, John G [0000-0003-2801-700X], Mason, Jeremy [0000-0002-2796-5123], Nutter, Lauryl MJ [0000-0001-9619-146X], Odfalk, Kristian F [0000-0003-4152-4583], Prochazka, Jan [0000-0003-4675-8995], Selloum, Mohammed [0000-0003-4057-3519], Spoutil, Frantisek [0000-0002-7310-3487], Svenson, Karen L [0000-0002-7928-1911], Vales, Taylor S [0000-0001-9751-5681], Wells, Sara E [0000-0002-0572-0600], White, Jacqueline K [0000-0001-6268-2826], Sedlacek, Radislav [0000-0002-3352-392X], Wurst, Wolfgang [0000-0003-4422-7410], Lloyd, KC Kent [0000-0002-5318-4144], Williams, Graham R [0000-0002-8555-8219], Herault, Yann [0000-0001-7049-6900], Brown, Steve DM [0000-0002-0617-4824], Hrabe de Angelis, Martin [0000-0002-7898-2353], and Apollo - University of Cambridge Repository
- Subjects
Male ,Osteoporosis ,genetics [Gene Expression Regulation] ,Transgenic ,Transcriptome ,Mice ,0302 clinical medicine ,Animal Cells ,Aetiology ,Musculoskeletal System ,Connective Tissue Cells ,Genetics & Heredity ,0303 health sciences ,Genomics ,3. Good health ,Cellular Types ,musculoskeletal diseases ,Genotype ,In silico ,1.1 Normal biological development and functioning ,03 medical and health sciences ,genetics [Osteoporosis] ,Rheumatology ,pathology [Osteoblasts] ,Genetic ,Genome-Wide Association Studies ,Genetics ,GENOME-WIDE ASSOCIATION ,Molecular Biology ,Skeleton ,Ecology, Evolution, Behavior and Systematics ,METAANALYSIS ,metabolism [Osteoblasts] ,0604 Genetics ,[SDV.GEN]Life Sciences [q-bio]/Genetics ,Science & Technology ,Osteoblasts ,IDENTIFICATION ,Biology and Life Sciences ,Computational Biology ,medicine.disease ,COLLAGEN ,Biological Tissue ,OSTEOGENESIS IMPERFECTA ,DISCOVERY ,IMPC Consortium ,Mutation ,Animal Studies ,Developmental Biology ,Candidate gene ,Cancer Research ,Bone density ,Gene Expression ,Osteoclasts ,[SDV.GEN] Life Sciences [q-bio]/Genetics ,QH426-470 ,Bone remodeling ,Bone Density ,Medicine and Health Sciences ,2.1 Biological and endogenous factors ,Protein Interaction Maps ,Connective Tissue Diseases ,Promoter Regions, Genetic ,Genetics (clinical) ,Bone mineral ,Sex Characteristics ,genetics [Bone Density] ,metabolism [Osteoclasts] ,Genetic Pleiotropy ,Animal Models ,pathology [Osteoclasts] ,Phenotype ,DIFFERENTIATION ,Experimental Organism Systems ,ANIMAL-MODELS ,Connective Tissue ,SEX ,Female ,Anatomy ,Technology Platforms ,Life Sciences & Biomedicine ,Research Article ,metabolism [Osteoporosis] ,Mouse Models ,030209 endocrinology & metabolism ,Mice, Transgenic ,Biology ,Research and Analysis Methods ,Promoter Regions ,Model Organisms ,Underpinning research ,medicine ,Animals ,ddc:610 ,Bone ,030304 developmental biology ,Human Genetics ,Cell Biology ,Genome Analysis ,Gene Ontology ,Gene Expression Regulation ,Musculoskeletal ,Genome-Wide Association Study - Abstract
The genetic landscape of diseases associated with changes in bone mineral density (BMD), such as osteoporosis, is only partially understood. Here, we explored data from 3,823 mutant mouse strains for BMD, a measure that is frequently altered in a range of bone pathologies, including osteoporosis. A total of 200 genes were found to significantly affect BMD. This pool of BMD genes comprised 141 genes with previously unknown functions in bone biology and was complementary to pools derived from recent human studies. Nineteen of the 141 genes also caused skeletal abnormalities. Examination of the BMD genes in osteoclasts and osteoblasts underscored BMD pathways, including vesicle transport, in these cells and together with in silico bone turnover studies resulted in the prioritization of candidate genes for further investigation. Overall, the results add novel pathophysiological and molecular insight into bone health and disease., Author summary Patients affected by osteoporosis frequently present with decreased BMD and increased fracture risk. Genes are known to control the onset and progression of bone diseases such as osteoporosis. Therefore, we aimed to identify osteoporosis-related genes using BMD measures obtained from a large pool of mutant mice genetically modified for deletion of individual genes (knockout mice). In a collaborative endeavor involving several research sites world-wide, we generated and phenotyped 3,823 knockout mice and identified 200 genes which regulated BMD. Of the 200 BMD genes, 141 genes were previously not known to affect BMD. The discovery and study of novel BMD genes will help to better understand the causes and therapeutic options for patients with low BMD. In the long run, this will improve the clinical management of osteoporosis.
- Published
- 2021
- Full Text
- View/download PDF
27. Importing genetically altered animals: ensuring quality
- Author
-
Guillaume Pavlovic, Edward Ryder, R. Matteoni, Marie-Christine Birling, Jan Rozman, Lydia Teboul, Ferdinando Scavizzi, Martin Fray, Lauryl M J Nutter, Marcello Raspa, Sara Wells, Petr Kasparek, J. Kopkanova, M. Massimi, V. Voikar, Lluis Montoliu, Biosciences, Neuroscience Center, French National Infrastructure for Mouse Phenogenomics (PHENOMIN), Institut Clinique de la Souris (ICS), Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), MRC Harwell, Institute of Molecular Genetics of the Czech Academy of Sciences (IMG / CAS), Czech Academy of Sciences [Prague] (CAS), CNR - Italian National Research Council (CNR), Centro Nacional de Biotecnología [Madrid] (CNB-CSIC), Consejo Superior de Investigaciones Científicas [Madrid] (CSIC), The Hospital for sick children [Toronto] (SickKids), The Wellcome Trust Sanger Institute [Cambridge], Helsingin yliopisto = Helsingfors universitet = University of Helsinki, and univOAK, Archive ouverte
- Subjects
EXPRESSION ,media_common.quotation_subject ,[SDV.GEN] Life Sciences [q-bio]/Genetics ,Biology ,MOUSE ,mouse mutant ,03 medical and health sciences ,0302 clinical medicine ,Documentation ,REPRODUCIBILITY ,Genetics ,Animals ,Humans ,Quality (business) ,030304 developmental biology ,media_common ,0303 health sciences ,[SDV.GEN]Life Sciences [q-bio]/Genetics ,disease model ,1184 Genetics, developmental biology, physiology ,Reproducibility of Results ,MICROBIOTA ,GENE ,Biological materials ,Research Personnel ,CRE RECOMBINASE ,RODENT ,MICE ,Risk analysis (engineering) ,CELLS ,RAT ,030217 neurology & neurosurgery - Abstract
The reproducibility of research using laboratory animals requires reliable management of their quality, in particular of their genetics, health and environment, all of which contribute to their phenotypes. The point at which these biological materials are transferred between researchers is particularly sensitive, as it may result in a loss of integrity of the animals and/or their documentation. Here, we describe the various aspects of laboratory animal quality that should be confirmed when sharing rodent research models. We also discuss how repositories of biological materials support the scientific community to ensure the continuity of the quality of laboratory animals. Both the concept of quality and the role of repositories themselves extend to all exchanges of biological materials and all networks that support the sharing of these reagents.
- Published
- 2021
- Full Text
- View/download PDF
28. Maternal and offspring high-fat diet leads to platelet hyperactivation in male mice offspring
- Author
-
Jonathan M. Gibbins, Tanya Sage, Alaa Al-Dibouni, Sara Wells, Amanda J. Unsworth, Renato Simões Gaspar, Dyan Sellayah, Craig E. Hughes, Michelle Stewart, Alexander P. Bye, and Roger D. Cox
- Subjects
0301 basic medicine ,Platelets ,Blood Platelets ,Male ,medicine.medical_specialty ,Offspring ,Science ,Weaning ,030204 cardiovascular system & hematology ,medicine.disease_cause ,Diet, High-Fat ,Article ,03 medical and health sciences ,Mice ,0302 clinical medicine ,Insulin resistance ,Pregnancy ,Diabetes mellitus ,Internal medicine ,medicine ,Ingestion ,Animals ,Lactation ,Platelet ,Obesity ,Adiposity ,Metabolic Syndrome ,Multidisciplinary ,Hyperactivation ,business.industry ,Metabolic diseases ,Maternal Nutritional Physiological Phenomena ,medicine.disease ,Platelet Activation ,Mice, Inbred C57BL ,030104 developmental biology ,Endocrinology ,Prenatal Exposure Delayed Effects ,Hypertension ,Medicine ,Female ,Insulin Resistance ,business ,Oxidative stress - Abstract
Maternal over-nutrition increases the risk of diabetes and cardiovascular events in offspring. While prominent effects on cardiovascular health are observed, the impact on platelet physiology has not been studied. Here, we examined whether maternal high-fat diet (HF) ingestion affects the platelet function in lean and obese offspring. C57BL6/N mice dams were given a HF or control (C) diet for 8 weeks before and during pregnancy. Male and female offspring received C or HF diets for 26 weeks. Experimental groups were: C/C, dam and offspring fed standard laboratory diet; C/HF dam fed standard laboratory diet and offspring fed HF diet; HF/C and HF/HF. Phenotypic and metabolic tests were performed and blood collected for platelet studies. Compared to C/C, offspring HF groups were obese, with fat accumulation, hyperglycaemia and insulin resistance. Female offspring did not present platelet hyperactivity, hence we focused on male offspring. Platelets from HF/HF mice were larger, hyperactive and presented oxidative stress when compared to C/C. Maternal and offspring HF diet results in platelet hyperactivation in male mouse offspring, suggesting a novel ‘double-hit’ effect.
- Published
- 2021
29. Gradations of Degradation: Ezekiel’s Underworld as a Temple of Doom
- Author
-
Sara Wells and Christopher B Hays
- Subjects
BS1-2970 ,Ezekiel, Underworld, Temple and Tabernacle, Priestly Literature, Mesopotamian literature, Gradations of holiness ,The Bible - Abstract
Ezekiel’s underworld is characterised by hierarchy and gradation. Insofar as that is also true of sacred spaces in the Bible, Ezekiel’s underworld can also be imagined, heuristically, as a kind of unholy temple. Each of the three primary descriptions of holy space in the Hebrew Bible (the Priestly tabernacle, Solomon’s temple, and Ezekiel’s temple) has three primary graded spaces (inner sanctum, outer sanctum, and court). Ezekiel’s underworld has three primary graded spaces: Sheol, the Pit, and the extremities of the Pit. In each case, the farther one moves in from the entrance, the more unholy the space. Like the tabernacle and temples, Ezekiel’s underworld also has further gradations within the primary space, and these finer gradations of unholiness are marked by factors such as the length of the passage dedicated to a nation and the presence of associates in the nation’s sphere of influence. https://doi.org/10.17159/2312-3621/2020/v33n3a8
- Published
- 2020
30. Age-related changes in the biophysical and morphological characteristics of mouse cochlear outer hair cells
- Author
-
David N. Furness, Stuart L. Johnson, Mirna Mustapha, Sara Wells, Michael R. Bowl, Adam J Carlton, Jing-Yi Jeng, Walter Marcotti, Lara De Tomasi, Matthew C. Holley, Francesca De Faveri, Steve D. M. Brown, Richard J. Goodyear, and Guy P. Richardson
- Subjects
0301 basic medicine ,medicine.medical_specialty ,Physiology ,Hearing loss ,Efferent ,Otoacoustic Emissions, Spontaneous ,Otoacoustic emission ,Biology ,Q1 ,Article ,Mice ,03 medical and health sciences ,0302 clinical medicine ,Postsynaptic potential ,RZ ,Internal medicine ,medicine ,otorhinolaryngologic diseases ,Animals ,Receptor ,Prestin ,Cochlea ,Mice, Inbred C3H ,Cadherins ,Mice, Inbred C57BL ,Hair Cells, Auditory, Outer ,030104 developmental biology ,Endocrinology ,Ageing ,biology.protein ,sense organs ,medicine.symptom ,030217 neurology & neurosurgery - Abstract
KEY POINTS: Age-related hearing loss (ARHL) is a very heterogeneous disease, resulting from cellular senescence, genetic predisposition and environmental factors (e.g. noise exposure). Currently, we know very little about age-related changes occurring in the auditory sensory cells, including those associated with the outer hair cells (OHCs). Using different mouse strains, we show that OHCs undergo several morphological and biophysical changes in the ageing cochlea. Ageing OHCs also exhibited the progressive loss of afferent and efferent synapses. We also provide evidence that the size of the mechanoelectrical transducer current is reduced in ageing OHCs, highlighting its possible contribution in cochlear ageing. ABSTRACT: Outer hair cells (OHCs) are electromotile sensory receptors that provide sound amplification within the mammalian cochlea. Although OHCs appear susceptible to ageing, the progression of the pathophysiological changes in these cells is still poorly understood. By using mouse strains with a different progression of hearing loss (C57BL/6J, C57BL/6NTac, C57BL/6NTacCdh23+ , C3H/HeJ), we have identified morphological, physiological and molecular changes in ageing OHCs (9-12 kHz cochlear region). We show that by 6 months of age, OHCs from all strains underwent a reduction in surface area, which was not a sign of degeneration. Although the ageing OHCs retained a normal basolateral membrane protein profile, they showed a reduction in the size of the K+ current and non-linear capacitance, a readout of prestin-dependent electromotility. Despite these changes, OHCs have a normal Vm and retain the ability to amplify sound, as distortion product otoacoustic emission thresholds were not affected in aged, good-hearing mice (C3H/HeJ, C57BL/6NTacCdh23+ ). The loss of afferent synapses was present in all strains at 15 months. The number of efferent synapses per OHCs, defined as postsynaptic SK2 puncta, was reduced in aged OHCs of all strains apart from C3H mice. Several of the identified changes occurred in aged OHCs from all mouse strains, thus representing a general trait in the pathophysiological progression of age-related hearing loss, possibly aimed at preserving functionality. We have also shown that the mechanoelectrical transduction (MET) current from OHCs of mice harbouring the Cdh23ahl allele is reduced with age, highlighting the possibility that changes in the MET apparatus could play a role in cochlear ageing.
- Published
- 2020
31. Phenotyping in Mice Using Continuous Home Cage Monitoring and Ultrasonic Vocalization Recordings
- Author
-
Patrick M. Nolan, Sara Wells, Rasneer Sonia Bains, Simon Greenaway, and Liane Hobson
- Subjects
Male ,0303 health sciences ,Computer science ,Mutagenesis (molecular biology technique) ,General Medicine ,Limiting ,Housing, Animal ,Social relation ,Mice, Inbred C57BL ,03 medical and health sciences ,Mice ,0302 clinical medicine ,Phenotype ,Genetic Techniques ,Home cage ,Animals ,Continuous recording ,Female ,Ultrasonics ,Vocalization, Animal ,Set (psychology) ,Neuroscience ,030217 neurology & neurosurgery ,030304 developmental biology - Abstract
Over the last century, the study of mouse behavior has uncovered insights into brain molecular mechanisms while revealing potential causes of many neurological disorders. To this end, researchers have widely exploited the use of mutant strains, including those generated in mutagenesis screens and those produced using increasingly sophisticated genome engineering technologies. It is now relatively easy to access mouse models carrying alleles that faithfully recapitulate changes found in human patients or bearing variants of genes that provide data on those genes' functions. Concurrent with these developments has been an appreciation of the limitations of some current testing platforms, especially those monitoring complex behaviors. Out-of-cage observational testing is useful in describing overt persistent phenotypes but risks missing sporadic or intermittent events. Furthermore, measuring the progression of a phenotype, potentially over many months, can be difficult while relying on assays that may be susceptible to changes in the testing environment. In recent years, there has also been increasing awareness that measurement of behaviors in isolation can be limiting, given that mice attempt to hide behavioral cues of vulnerability. To overcome these limitations, laboratory animal science is capitalizing on progress in data capture and processing expertise. Moreover, as additional recording modes become commonplace, ultrasonic vocalization recording is an appealing focus, as mice use vocalizations in various social contexts. Using video and audio technologies, we record the voluntary, unprovoked behaviors and vocalizations of mice in social groups. Adoption of these approaches is undoubtedly set to increase, as they capture the round-the-clock behavior of mouse strains. © 2020 Wiley Periodicals LLC. Basic Protocol 1: Continuous recording of home cage activity using the Home Cage Analyzer (HCA) system Support Protocol: Subcutaneous insertion of a radio frequency identification microchip in the inguinal area Basic Protocol 2: Continuous recording of mouse ultrasonic vocalizations in the home cage.
- Published
- 2020
32. Ap2s1 mutation in mice causes familial hypocalciuric hypercalcemia type 3
- Author
-
Rajesh V. Thakker, Michelle Stewart, Mark Stevenson, Fadil M. Hannan, Lydia Teboul, Asha L. Bayliss, Sara Wells, Gemma F. Codner, Victoria Stokes, Kreepa Kooblall, and Caroline M Gorvin
- Subjects
Fibroblast growth factor 23 ,Mutation ,medicine.medical_specialty ,Osteomalacia ,Cinacalcet ,Familial hypocalciuric hypercalcemia ,Chemistry ,Parathyroid hormone ,medicine.disease_cause ,medicine.disease ,Endocrinology ,Internal medicine ,medicine ,Missense mutation ,Hypophosphatemia ,medicine.drug - Abstract
Mutations of the adaptor protein-2 sigma subunit (AP2S1) gene which encodes AP2σ2, a component of the ubiquitous AP2 heterotetrameric complex involved in endosomal trafficking of the calcium-sensing receptor (CaSR), cause familial hypocalciuric hypercalcemia type 3 (FHH3). FHH3 patients have heterozygous AP2S1 missense Arg15 mutations (p.Arg15Cys, p.Arg15His or p.Arg15Leu) with marked hypercalcemia and occasional hypophosphatemia and osteomalacia. To further characterise the phenotypic spectrum and calcitropic pathophysiology of FHH3, we used CRISPR/Cas9 genome editing to generate mice harboring the AP2S1 p.Arg15Leu mutation, which causes the most severe FHH3 phenotype. Heterozygous (Ap2s1+/L15) mice were viable, and had marked hypercalcemia, hypermagnesemia, hypophosphatemia, and increased plasma concentrations of parathyroid hormone, fibroblast growth factor 23 and alkaline phosphatase activity, but normal pro-collagen type 1 N-terminal pro-peptide and 1,25 dihydroxyvitamin D. Homozygous (Ap2s1L15/L15) mice invariably died perinatally. The AP2S1 p.Arg15Leu mutation impaired protein-protein interactions between AP2σ2 and the other AP2 subunits, and the CaSR. Cinacalcet, a CaSR allosteric activator, ameliorated the hypercalcemia and elevated PTH concentrations, but not the diminished AP2σ2-CaSR interaction. Thus, our studies have established a mouse model with a germline loss-of-function AP2S1 mutation that is representative for FHH3 in humans, and demonstrated that cinacalcet corrects the abnormalities of plasma calcium and PTH.
- Published
- 2020
33. Maternal High-fat Diet During Pregnancy Programs Platelet Hyperactivation in Male Mouse Offspring
- Author
-
Michelle Stewart, Jonathan M. Gibbins, Tanya Sage, Dyan Sellayah, Amanda J. Unsworth, Roger D. Cox, Renato Simões Gaspar, Sara Wells, Craig E. Hughes, and Alexander P. Bye
- Subjects
medicine.medical_specialty ,Pregnancy ,Hyperactivation ,business.industry ,Offspring ,medicine.disease_cause ,medicine.disease ,Endocrinology ,Insulin resistance ,Internal medicine ,Diabetes mellitus ,Medicine ,Ingestion ,Platelet ,business ,Oxidative stress - Abstract
Background: Maternal over-nutrition increases the risk of diabetes and cardiovascular events in offspring. While prominent effects on cardiovascular health are observed, the impact of this on platelet physiology has not been studied. Here, we sought to determine whether maternal high-fat diet (HF) ingestion can affect the platelet function in offspring.Methods: C57BL6/N mice dams were given a HF or control (C) diet for 8 weeks prior to and during pregnancy. Male offspring also received either C or HF diets for 26 weeks. Experimental groups were: C/C, dam and offspring fed chow; C/HF dam fed chow and offspring fed high-fat diet; HF/C and HF/HF. Various phenotypic (including body weight and % of body fat) and metabolic (glycaemia, triglyceridemia) tests were performed and blood collected for platelet studies. Results: Compared to C/C, HF/HF animals were obese, with fat accumulation, hyperglycaemia, insulin resistance and low respiratory exchange rate. HF/HF, but not C/HF mice also showed hypertriglyceredaemia and higher mean platelet volume. These platelets were hyperreactive, displaying higher fibrinogen binding after stimulation with different agonists. They also showed increased platelet adhesion and spreading on collagen. Maternal obesity led to an overall effect of increased platelet reactivity in offspring. Both maternal and offspring HF groups presented decreased levels of collagen receptor GPVI with increased oxidative stress. Western blotting experiments in stimulated platelets showed increased phosphorylation of PKC substrates, total tyrosine and AKT at Ser473, whilst response to nitric oxide donor PAPA-NONOate was unchanged compared to C/C.Conclusions: Maternal HF diet ingestion programmes platelet hyperactivation in male mouse offspring, whilst HF in both dams and offspring resulted in a 'double-hit' effect of increased serum triglyceride levels, large platelets and increased reactivity. This involved enhanced Tyr phosphorylation, ROS production and decreased GPVI expression. Since platelet function can be programmed by early developmental periods, it is possible to use this window of intervention to reduce the risk of thrombotic events.
- Published
- 2020
34. LAMA: Automated image analysis for developmental phenotyping of mouse embryos
- Author
-
Ramón Casero, Sara Wells, Neil R. Horner, Sara Johnson, Henrik Westerberg, Steve D.M. Brown, Lydia Teboul, James M. Brown, Ann-Marie Mallon, and Shanmugasundaram Venkataraman
- Subjects
0303 health sciences ,education.field_of_study ,Computer science ,business.industry ,Population ,ComputingMethodologies_IMAGEPROCESSINGANDCOMPUTERVISION ,Image registration ,Imaging modalities ,03 medical and health sciences ,0302 clinical medicine ,Post coitus ,Computer vision ,Artificial intelligence ,business ,education ,030217 neurology & neurosurgery ,030304 developmental biology - Abstract
Advanced 3D imaging modalities such as micro computed tomography (micro-CT), high resolution episcopic microscopy (HREM), and optical projection tomography (OPT) have been readily incorporated into high-throughput phenotyping pipelines, such as the International Mouse Phenotyping Consortium (IMPC). Such modalities generate large volumes of raw data that cannot be immediately harnessed without significant resources of manpower and expertise. Thus, rapid automated analysis and annotation is critical to ensure that 3D imaging data is able to be integrated with other multi-dimensional phenotyping data. To this end, we present an automated computational mouse phenotyping pipeline called LAMA, based on image registration, which requires minimal technical expertise and human input to use. Designed predominantly for developmental biologists, our software performs image pre-processing, registration, statistical and gene function annotation, and segmentation of 3D micro-CT data. We address several limitations of current methods and create an easy to use, fast solution application for mouse embryo phenotyping. We also present a highly granular, novel anatomical E14.5 (14.5 days post coitus) atlas of a population average that integrates with our pipeline to allow a range of dysmorphologies to be automatically annotated as well as results from the validation of the pipeline.
- Published
- 2020
- Full Text
- View/download PDF
35. Accelerating the Evolution of Nonhuman Primate Neuroimaging
- Author
-
Olivier Coulon, Michael P. Milham, Patrik Lindenfors, Karl-Heinz Nenning, Xiaojin Liu, Ravi S. Menon, Stephanie J. Forkel, Adam Messinger, Zheng Wang, Alexander Thiele, Luciano Simone, Benjamin Jung, Chika Sato, Jamie Nagy, Sean Froudist-Walsh, Kelvin Mok, Renée Hartig, Julien Sein, Alessandro Gozzi, Julien Vezoli, Tomoko Sakai, Lynn Uhrig, Martine Meunier, Christienne G. Damatac, Bonhwang Koo, Roberto Toro, Rogier B. Mars, Henrietta Howells, Lea Roumazeilles, Ming Zhan, Ann-Marie Mallon, Román Rossi-Pool, Elinor L. Sullivan, Yannick Becker, Doris Y. Tsao, Antoine Grigis, Lei Ai, Céline Amiez, Sara Wells, Reza Rajimehr, Aki Nikolaidis, Anna S. Mitchell, Simon M. Reader, Michele A. Basso, Béchir Jarraya, Amir Raz, Wim Vanduffel, Charles R.E. Wilson, Brian E. Russ, Christopher R. Madan, Orlin S. Todorov, Wasana Madushanka, Carole Guedj, Mark A. Pinsk, Clémentine Bodin, Hugo Merchant, Jennifer Nacef, Damien A. Fair, Anna W. Roe, Sze Chai Kwok, Stephen J. Sawiak, Essa Yacoub, Bastien Cagna, Kevin N. Laland, Wilbert Zarco, Charles E. Schroeder, Ting Xu, P. Christiaan Klink, Stanislas Dehaene, Takuya Hayashi, Matthew F. S. Rushworth, Amir Shmuel, Fadila Hadj-Bouziane, Katja Heuer, Ioana-Sabina Rautu, Andrew S. Fox, Austin Benn, Sabine Kastner, Thomas Brochier, Emmanuel Procyk, Marco Pagani, David C. Van Essen, Frank Q. Ye, Dirk Jan Ardesch, Régis Trapeau, Jakob Seidlitz, Marike Schiffer, Bassem Hiba, John H. Morrison, David A. Rudko, Paula L. Croxson, Patrick Friedrich, Augix Guohua Xu, Lazar Fleysher, Piotr Majka, Jonathan Smallwood, Aihua Chen, Timothy D. Griffiths, Fabien Balezeau, Stefan Everling, Michael C. Schmid, Robert Leech, Leslie G. Ungerleider, Mark G. Baxter, Afonso C. Silva, Clare Kelly, Zhi-ming Shen, Daniel S. Margulies, Mark J. Prescott, Pascal Belin, Erwin L. A. Blezer, Igor Kagan, Suliann Ben Hamed, David A. Leopold, Adrien Meguerditchian, Wendy Jarrett, Michel Thiebaut de Schotten, Nikoloz Sirmpilatze, Julia Sliwa, Henry Kennedy, Vikas Pareek, Yong-di Zhou, Michael Ortiz-Rios, Sherif Hamdy El-Gohary, Susann Boretius, Christopher I. Petkov, Pamela Garcia-Saldivar, Bella Williams, Jordy Tasserie, Hank P. Jedema, Jerome Sallet, Pieter R. Roelfsema, Winrich A. Freiwald, Eduardo A. Garza-Villarreal, Noam Harel, Caspar M. Schwiedrzik, Kevin Marche, Colline Poirier, Yang Gao, Henry C. Evrard, Ashkan Alvand, ANS - Cellular & Molecular Mechanisms, Laboratoire des Sciences de l'Information et des Systèmes (LSIS), Aix Marseille Université (AMU)-Université de Toulon (UTLN)-Arts et Métiers Paristech ENSAM Aix-en-Provence-Centre National de la Recherche Scientifique (CNRS), Institut cellule souche et cerveau (SBRI), Institut National de la Recherche Agronomique (INRA)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM), Collège de France - Chaire Psychologie cognitive expérimentale, Collège de France (CdF (institution)), Institut des sciences cognitives Marc Jeannerod - Centre de neuroscience cognitive - UMR5229 (ISC-MJ), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS), Consortium, PRIMatE Data Exchange Global Collaboration Workshop and, Nathan S. Kline Institute for Psychiatric Research (NKI), New York State Office of Mental Health, Newcastle University [Newcastle], Max Planck Institute for Human Cognitive and Brain Sciences [Leipzig] (IMPNSC), Max-Planck-Gesellschaft, Medical Oncology, Department of Internal Medicine, Università Cattolica del Sacro Cuore [Roma] (Unicatt), Voice Neurocognition Laboratory, University of Glasgow, Oregon Health and Science University [Portland] (OHSU), Manchester Royal Infirmary, University of Manchester [Manchester], Princeton Neuroscience Institute [Princeton], University of Pennsylvania [Philadelphia], National Institute of Mental Health (NIMH), Harvard Medical School [Boston] (HMS), Washington University in St Louis, Laboratoire de psychologie cognitive (LPC), Centre National de la Recherche Scientifique (CNRS)-Aix Marseille Université (AMU), Institut des sciences cognitives Marc Jeannerod - Centre de neuroscience cognitive - UMR5229 (CNC), Centre National de la Recherche Scientifique (CNRS)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon, Institut de Neurosciences de la Timone (INT), Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS), Institute of Psychiatry, Psychology & Neuroscience, King's College London, King‘s College London, New York University [New York] (NYU), NYU System (NYU), State Key Laboratory of Novel Software Technology, University of Nanjing, Center for Nanotechnology Innovation, @NEST (CNI), National Enterprise for nanoScience and nanoTechnology (NEST), Scuola Normale Superiore di Pisa (SNS)-Scuola Universitaria Superiore Sant'Anna [Pisa] (SSSUP)-Istituto Italiano di Tecnologia (IIT)-Consiglio Nazionale delle Ricerche [Pisa] (CNR PISA)-Scuola Normale Superiore di Pisa (SNS)-Scuola Universitaria Superiore Sant'Anna [Pisa] (SSSUP)-Istituto Italiano di Tecnologia (IIT)-Consiglio Nazionale delle Ricerche [Pisa] (CNR PISA), Unité Analyse et Traitement de l'Information (UNATI), Service NEUROSPIN (NEUROSPIN), Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris-Saclay-Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris-Saclay, Neuroimagerie cognitive - Psychologie cognitive expérimentale (UNICOG-U992), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Saclay (COmUE), Institut cellule souche et cerveau (U846 Inserm - UCBL1), Royal Netherlands Academy of Arts and Sciences (KNAW), East China Normal University [Shangaï] (ECNU), The Computational, Cognitive and Clinical Neuroimaging Lab, Imperial College London, Medical Research Council Harwell (Mammalian Genetics Unit and Mary Lyon Centre), Medical Research Counc, Station de primatologie (SP), Centre National de la Recherche Scientifique (CNRS), Institute of Language, Communication and the Brain (ILCB), The University of Western Ontario, Instituto de Neurobiología, Universidad Nacional Autónoma de México (UNAM), Institute of integrative biology (Liverpool), University of Liverpool, McGovern Institute for Brain Research [Cambridge], Massachusetts Institute of Technology (MIT), University of Cambridge [UK] (CAM), Rockefeller University [New York], McConnell Brain Imaging Centre (MNI), Montreal Neurological Institute and Hospital, McGill University = Université McGill [Montréal, Canada]-McGill University = Université McGill [Montréal, Canada], Laboratory for Neuro- and Psychofysiology, katho, Institut du Cerveau et de la Moëlle Epinière = Brain and Spine Institute (ICM), Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP], Sorbonne Université-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), University of York [York, UK], Centre de Recherche de l'Institut du Cerveau et de la Moelle épinière (CRICM), Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Pierre et Marie Curie - Paris 6 (UPMC), Génétique Humaine et Fonctions Cognitives, Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS), Tianjin University of Science and Technology (TUST), Child Mind Institute, Center for Magnetic Resonance Research [Minneapolis] (CMRR), University of Minnesota Medical School, University of Minnesota System-University of Minnesota System, Institut cellule souche et cerveau / Stem Cell and Brain Research Institute (U1208 Inserm - UCBL1 / SBRI), Icahn School of Medicine at Mount Sinai [New York] (MSSM), University Medical Center [Utrecht], Radboud university [Nijmegen], Chaire Psychologie cognitive expérimentale, Centre de recherche en neurosciences de Lyon (CRNL), Université de Lyon-Université de Lyon-Université Jean Monnet [Saint-Étienne] (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), University of St Andrews [Scotland], Stockholm University, Hôpital du Bocage, Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Princeton University, Utrecht University [Utrecht], Netherlands Institute for Neuroscience, Wellcome Trust Centre for Integrative Neuroimaging (WIN - FMRIB), University of Oxford [Oxford], National Institute of Environmental Health Sciences [Durham] (NIEHS-NIH), National Institutes of Health [Bethesda] (NIH), Oregon National Primate Research Center (ONPRC), California Institute of Technology (CALTECH), Johns Hopkins University (JHU), The PRIMatE Data Exchange (PRIME-DE) Global Collaboration Workshop and Consortium, ANR-16-CONV-0002,ILCB,ILCB: Institute of Language Communication and the Brain(2016), Amsterdam Neuroscience - Complex Trait Genetics, Amsterdam Neuroscience - Cellular & Molecular Mechanisms, Complex Trait Genetics, Centre National de la Recherche Scientifique (CNRS)-Arts et Métiers Paristech ENSAM Aix-en-Provence-Université de Toulon (UTLN)-Aix Marseille Université (AMU), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Recherche Agronomique (INRA), and Vanduffel, Wim
- Subjects
Primates ,0301 basic medicine ,[SDV.IB.IMA]Life Sciences [q-bio]/Bioengineering/Imaging ,education ,Neuroimaging ,Article ,[SPI]Engineering Sciences [physics] ,03 medical and health sciences ,0302 clinical medicine ,London ,Psychology ,Animals ,Humans ,Sociology ,ComputingMilieux_MISCELLANEOUS ,Cognitive science ,Science & Technology ,Human Connectome Project ,[SDV.NEU.PC]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Psychology and behavior ,Action, intention, and motor control ,Information Dissemination ,General Neuroscience ,Neurosciences ,Brain ,[SDV.NEU.SC]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Cognitive Sciences ,Congresses as Topic ,Nonhuman primate ,030104 developmental biology ,[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC] ,Neurosciences & Neurology ,Life Sciences & Biomedicine ,[SPI.SIGNAL]Engineering Sciences [physics]/Signal and Image processing ,030217 neurology & neurosurgery - Abstract
Contains fulltext : 217200.pdf (Publisher’s version ) (Closed access) Nonhuman primate neuroimaging is on the cusp of a transformation, much in the same way its human counterpart was in 2010, when the Human Connectome Project was launched to accelerate progress. Inspired by an open data-sharing initiative, the global community recently met and, in this article, breaks through obstacles to define its ambitions. 4 p.
- Published
- 2020
36. Forward genetics identifies a novel sleep mutant with sleep state inertia and REM sleep deficits
- Author
-
Elizabeth Nicholson, Mathilde C. C. Guillaumin, Michael R. Bowl, Patrick M. Nolan, Stuart N. Peirson, Laurence A. Brown, Sibah Hasan, Nora Bourbia, Minghui Yin, Sara Wells, Vladyslav V. Vyazovskiy, Gareth Banks, Rasneer Sonia Bains, Kirill E. Volynski, Ines Heise, Carlos A. Aguilar, Christopher T. Esapa, Petrina Lau, and Erica Tagliatti
- Subjects
Sleep state ,media_common.quotation_subject ,Mutant ,Sleep, REM ,Biology ,03 medical and health sciences ,Mice ,0302 clinical medicine ,Genetics ,Animals ,Wakefulness ,Research Articles ,030304 developmental biology ,media_common ,0303 health sciences ,Multidisciplinary ,VAMP2 ,Eye movement ,SciAdv r-articles ,Brain ,Forward genetics ,Electrophysiological Phenomena ,Electrophysiology ,sense organs ,Sleep ,Neuroscience ,030217 neurology & neurosurgery ,Vigilance (psychology) ,Research Article - Abstract
Switches between global sleep and wakefulness states are believed to be dictated by top-down influences arising from subcortical nuclei. Using forward genetics and in vivo electrophysiology, we identified a recessive mouse mutant line characterized by a substantially reduced propensity to transition between wake and sleep states with an especially pronounced deficit in initiating rapid eye movement (REM) sleep episodes. The causative mutation, an lle102Asn substitution in the synaptic vesicular protein, VAMP2, was associated with morphological synaptic changes and specific behavioral deficits, while in vitro electrophysiological investigations with fluorescence imaging revealed a markedly diminished probability of vesicular release in mutants. Our data show that global shifts in the synaptic efficiency across brain-wide networks leads to an altered probability of vigilance state transitions, possibly as a result of an altered excitability balance within local circuits controlling sleep-wake architecture., Science Advances, 6 (33), ISSN:2375-2548
- Published
- 2020
37. Aberrant synaptic release underlies sleep/wake transition deficits in a mouse Vamp2 mutant
- Author
-
Mathilde C. C. Guillaumin, Sara Wells, Nora Bourbia, Erica Tagliatti, Laurence A. Brown, Kirill E. Volynski, Petrina Lau, Christopher T. Esapa, Minghui Yin, Rasneer Sonia Bains, Michael R. Bowl, Sibah Hasan, Patrick M. Nolan, Stuart N. Peirson, Vladyslav V. Vyazovskiy, Gareth Banks, Elizabeth Nicholson, Carlos A. Aguilar, and Ines Heise
- Subjects
Brain network ,0303 health sciences ,VAMP2 ,media_common.quotation_subject ,Sleep wake ,Mutant ,Biology ,Forward genetics ,In vivo electrophysiology ,03 medical and health sciences ,Electrophysiology ,0302 clinical medicine ,Neuroscience ,030217 neurology & neurosurgery ,030304 developmental biology ,Vigilance (psychology) ,media_common - Abstract
Sleep-wake transitions are modulated through extensive subcortical networks although the precise roles of their individual components remain elusive. Using forward genetics and in vivo electrophysiology, we identified a recessive mouse mutant line characterised by a reduced propensity to transition between all sleep states while a profound loss in total REM sleep time was evident. The causative mutation, an Ile102Asn substitution in VAMP2, was associated with substantial synaptic changes while in vitro electrophysiological investigations with fluorescence imaging revealed a diminished probability of vesicular release in mutants. We conclude that the synaptic efficiency of the entire subcortical brain network determines the likelihood that an animal transitions from one vigilance state to the next.
- Published
- 2020
38. Gradations of Degradation: Ezekiel's Underworld as a Temple of Doom
- Author
-
Christopher B. Hays and Sara Wells
- Subjects
Linguistics and Language ,Archeology ,History ,media_common.quotation_subject ,Religious studies ,Art ,Mesopotamian literature ,Ancient history ,Temple and Tabernacle ,Priestly literature ,Language and Linguistics ,medicine.anatomical_structure ,Gradations of holiness ,Temple ,medicine ,Underworld ,Ezekiel ,Hebrew Bible ,media_common - Abstract
Ezekiel's underworld is characterised by hierarchy and gradation. Insofar as that is also true of sacred spaces in the Bible, Ezekiel's underworld can also be imagined, heuristically, as a kind of unholy temple. Each of the three primary descriptions of holy space in the Hebrew Bible (the Priestly tabernacle, Solomon's temple, and Ezekiel's temple) has three primary graded spaces (inner sanctum, outer sanctum, and court). Ezekiel's underworld has three primary graded spaces: Sheol, the Pit, and the extremities of the Pit. In each case, the farther one moves in from the entrance, the more unholy the space. Like the tabernacle and temples, Ezekiel's underworld also has further gradations within the primary space, and these finer gradations of unholiness are marked by factors such as the length of the passage dedicated to a nation and the presence of associates in the nation's sphere of influence. Keywords: Ezekiel, Underworld, Temple and Tabernacle, Priestly literature, Mesopotamian literature, Gradations of holiness
- Published
- 2020
39. The Deep Genome Project
- Author
-
Martin Hrabé de Angelis, Radislav Sedlacek, Paul Flicek, Sara Wells, Ann-Marie Mallon, James R. Lupski, Jason D. Heaney, Calum A. MacRae, Gareth Baynam, Michael S. Pepper, Mark J. Caulfield, Stanislas Lyonnet, Kevin C K Lloyd, Ying Xu, Stephen A. Murray, Arthur L. Beaudet, Yann Herault, David Valle, Chi-Kuang Leo Wang, Yuichi Obata, David J. Adams, Michael S. Dobbie, Damian Smedley, Mary E. Dickinson, Fatima Bosch, Roderick R. McInnes, Wolfgang Wurst, Robert Braun, Anne Grobler, Lauryl M. J. Nutter, Glauco P. Tocchini-Valentini, Helen Parkinson, Terrence F. Meehan, Ann M Flenniken, Sanjeev Galande, Fabio Mammano, Je Kyung Seong, Kym M. Boycott, Ronald Cohn, Colin McKerlie, Xiang Gao, Toshihiko Shiroishi, Jacqueline K. White, Steve D. M. Brown, University of California [Davis] (UC Davis), University of California, Genetic Services of Western Australia, King Edward Memorial Hospital [Mumbai], Department of Molecular and Human Genetics, Baylor College of Medicine (BCM), Baylor University-Baylor University, Department of Biochemistry and Molecular Biology [Bellaterra, Spain], Universitat Autònoma de Barcelona (UAB)-School of Veterinary Medicine [Bellaterra, Spain], University of Ottawa [Ottawa], Centre National de la Recherche Scientifique (CNRS), and 11008857 - Grobler, Anne Frederica
- Subjects
lcsh:QH426-470 ,Bioinformatics ,In silico ,[SDV]Life Sciences [q-bio] ,ved/biology.organism_classification_rank.species ,Computational biology ,Biology ,VARIANTS ,MOUSE ,Genome ,DNA sequencing ,null mutations ,03 medical and health sciences ,Mice ,0302 clinical medicine ,Genome editing ,ddc:570 ,Information and Computing Sciences ,Animals ,Humans ,mouse models ,Model organism ,lcsh:QH301-705.5 ,Gene ,ComputingMilieux_MISCELLANEOUS ,030304 developmental biology ,0303 health sciences ,ved/biology ,Proteins ,Genome project ,Biological Sciences ,genetics [Proteins] ,Human genetics ,3. Good health ,lcsh:Genetics ,Editorial ,Phenotype ,lcsh:Biology (General) ,Genes ,Mutation ,genetics [Mice] ,International Mouse Phenotyping Consortium ,functional genomics ,030217 neurology & neurosurgery ,Environmental Sciences - Abstract
In vivo research is critical to the functional dissection of multi-organ systems and whole organism physiology, and the laboratory mouse remains a quintessential animal model for studying mammalian, especially human, pathobiology. Enabled by technological innovations in genome sequencing, mutagenesis and genome editing, phenotype analyses, and bioinformatics, in vivo analysis of gene function and dysfunction in the mouse has delivered new understanding of the mechanisms of disease and accelerated medical advances. However, many significant hurdles have limited the elucidation of mechanisms underlying both rare and complex, multifactorial diseases, leaving significant gaps in our scientific knowledge. Future progress in developing a functionally annotated genome map depends upon studies in model organisms, not least the mouse. Further, recent advances in genetic manipulation and in vivo, in vitro, and in silico phenotyping technologies in the mouse make annotation of the vast majority of functional elements within the mammalian genome feasible. The implementation of a Deep Genome Project—to deliver the functional biological annotation of all human orthologous genomic elements in mice—is an essential and executable strategy to transform our understanding of genetic and genomic variation in human health and disease that will catalyze delivery of the promised benefits of genomic medicine to children and adults around the world.
- Published
- 2020
40. Universal Southern blot protocol with cold or radioactive probes for the validation of alleles obtained by homologous recombination
- Author
-
Lauren Chessum, Sara Wells, Lydia Teboul, Adam Caulder, Nicolas Jullien, Jorik Loeffler, Marie-Christine Birling, Gemma F. Codner, Valerie Erbs, Jullien, Nicolas, Mary Lyon Centre, MRC Harwell Institute, Institut Clinique de la Souris (ICS), Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Institut de neurophysiopathologie (INP), Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS), and Centre National de la Recherche Scientifique (CNRS)-Aix Marseille Université (AMU)
- Subjects
0303 health sciences ,[SDV.BA] Life Sciences [q-bio]/Animal biology ,[SDV.BA]Life Sciences [q-bio]/Animal biology ,030302 biochemistry & molecular biology ,Genetic Vectors ,Computational biology ,Biology ,Genome ,General Biochemistry, Genetics and Molecular Biology ,03 medical and health sciences ,Blotting, Southern ,Mice ,Radioactivity ,Gene Targeting ,Animals ,Allele ,Homologous recombination ,Homologous Recombination ,Molecular Biology ,Gene ,Alleles ,ComputingMilieux_MISCELLANEOUS ,030304 developmental biology ,Southern blot - Abstract
The widespread availability of recombineered vectors and gene targeted embryonic stem cells from large-scale repositories facilitates the generation of mouse models for functional genetic studies. Southern blotting validates the structure of these targeted alleles produced by homologous recombination, as well as indicating any additional integrations of the vector into the genome. Traditionally this technique employs radioactively-labelled probes; however, there are many laboratories that are restricted in their use of radioactivity. Here, we present a widely applicable protocol for Southern blot analysis using cold probes and alternative procedures employing radioactive probes. Furthermore, the probes are designed to recognise standardised regions of gene-targeting cassettes and so represent universally applicable reagents for assessing allelic integrity.
- Published
- 2020
41. The occurrence of tarsal injuries in male mice of C57BL/6N substrains in multiple international mouse facilities
- Author
-
Bonnie L. Lyons, Juan Antonio Aguilar-Pimentel, Colin McKerlie, Sara Wells, Michelle Stewart, Eleanor Herbert, John R. Seavitt, Rosalinda A Doty, Jean-Paul Wiegand, Liane Hobson, Ann M Flenniken, Lauryl M. J. Nutter, Brenda Kick, Dawei Qu, Jacqueline K. White, Martin Hrabe de Angelis, Marie Hutchison, Mary E Dickinson, and Cheryl L. Scudamore
- Subjects
Male ,0301 basic medicine ,Internationality ,Adult male ,Physiology ,Inbred Strains ,Social Sciences ,Male mice ,Hindlimb ,Diagnostic Radiology ,Tendons ,Mice ,0302 clinical medicine ,Skeletal Joints ,Medicine and Health Sciences ,Psychology ,Medicine ,Animal Husbandry ,Musculoskeletal System ,Animal Management ,Histological examination ,Mammals ,0303 health sciences ,Multidisciplinary ,Animal Behavior ,Radiology and Imaging ,Eukaryota ,Agriculture ,Anatomy ,Bone Imaging ,3. Good health ,Experimental Organism Systems ,Connective Tissue ,Lameness ,Vertebrates ,Gait Analysis ,Research Article ,animal structures ,Imaging Techniques ,Science ,C57bl 6n ,Research and Analysis Methods ,Animal Welfare ,Rodents ,03 medical and health sciences ,Diagnostic Medicine ,Animals ,030304 developmental biology ,Behavior ,Biological Locomotion ,business.industry ,Organisms ,Biology and Life Sciences ,Tarsal Bones ,X-Ray Radiography ,Mice, Inbred C57BL ,body regions ,Biological Tissue ,030104 developmental biology ,Amniotes ,Animal Studies ,Calcaneus ,Tomography, X-Ray Computed ,business ,Zoology ,030217 neurology & neurosurgery ,Sudden onset - Abstract
Dislocation in hindlimb tarsals are being observed at a low, but persistent frequency in adult male mice from C57BL/6N substrains. Clinical signs included a sudden onset of mild to severe unilateral or bilateral tarsal abduction, swelling, abnormal hindlimb morphology and lameness. Contraction of digits and gait abnormalities were noted in multiple cases. Radiographical and histological examination revealed caudal dislocation of the calcaneus and partial dislocation of the calcaneoquartal (calcaneous-tarsal bone IV) joint. The detection, frequency, and cause of this pathology in five large mouse production and phenotyping centres (MRC Harwell, UK; The Jackson Laboratory, USA; The Centre for Phenogenomics, Canada; German Mouse Clinic, Germany; Baylor College of Medicine, USA) are discussed.
- Published
- 2020
42. Genome editing for all?
- Author
-
Sara, Wells and Jan-Bas, Prins
- Subjects
Gene Editing ,General Veterinary ,Animal Science and Zoology - Published
- 2022
43. Characterisation and use of a functional Gadd45g bacterial artificial chromosome
- Author
-
Nick Warr, Sara Wells, Lydia Teboul, Maki Asami, Toru Suzuki, Joel May, Anthony C.F. Perry, and Andy Greenfield
- Subjects
0301 basic medicine ,Male ,Chromosomes, Artificial, Bacterial ,Transgene ,lcsh:Medicine ,Mice, Transgenic ,Biology ,Regulatory Sequences, Nucleic Acid ,Article ,03 medical and health sciences ,Mice ,Gene expression ,Testis ,Animals ,Transgenes ,lcsh:Science ,Gene ,Regulation of gene expression ,Bacterial artificial chromosome ,Multidisciplinary ,lcsh:R ,Intracellular Signaling Peptides and Proteins ,Gene Expression Regulation, Developmental ,Cell biology ,030104 developmental biology ,DNA demethylation ,Regulatory sequence ,GADD45G ,lcsh:Q ,Genetic Engineering - Abstract
Bacterial artificial chromosomes (BACs) offer a means of manipulating gene expression and tagging gene products in the mammalian genome without the need to alter endogenous gene structure and risk deleterious phenotypic consequences. However, for a BAC clone to be useful for such purposes it must be shown to contain all the regulatory elements required for normal gene expression and allow phenotypic rescue in the absence of an endogenous gene. Here, we report identification of a functional BAC containing Gadd45g, a gene implicated in DNA repair, DNA demethylation and testis determination in mice and exhibiting a broad pattern of embryonic expression. Mouse fetuses lacking the endogenous Gadd45g gene undergo normal testis development in the presence of the Gadd45g BAC transgene. Moreover, a survey of embryonic Gadd45g expression from the BAC reveals that all reported sites of expression are maintained. This functional BAC can now be used for subsequent manipulation of the Gadd45g gene with the confidence that regulatory elements required for embryonic expression, including testis determination, are present. We describe the generation and characterisation of a Gadd45g-mCherry fluorescent reporter exhibiting strong expression in developing gonads and neural tissue, recapitulating endogenous gene expression, as evidence of this.
- Published
- 2018
44. ZNRF3 functions in mammalian sex determination by inhibiting canonical WNT signaling
- Author
-
Silvia Corrochano, Abigail Harris, Hans Clevers, Caroline Eozenou, Isabelle Stévant, Joelle Bignon-Topalovic, Nick Warr, Neila Belguith, Sara Wells, Bochra Ben Rhouma, Pam Siggers, Serge Nef, Daniel T. Grimes, Ken McElreavey, Rebecca D. Burdine, Feng Cong, Makoto Suzuki, Andy Greenfield, Danielle Sagar, Anu Bashamboo, Bon-Kyoung Koo, Raja Brauner, Medical Research Coucil Harwell [Oxford, UK] (MRC Harwell), MRC Harwell, Department of Molecular Biology [Princeton], Princeton University, Novartis Institutes for BioMedical Research (NIBR), Hubrecht Institute [Utrecht, Netherlands], University Medical Center [Utrecht]-Royal Netherlands Academy of Arts and Sciences (KNAW), Université de Genève = University of Geneva (UNIGE), Fondation Ophtalmologique Adolphe de Rothschild [Paris], Université Paris Descartes - Paris 5 (UPD5), Faculté de médecine - Faculty of Medicine [Sfax, Tunisie] (FMS), Université de Sfax - University of Sfax, Génétique du Développement humain - Human developmental genetics, Institut Pasteur [Paris] (IP), This work was supported by the Medical Research Council by core funding Grant MC_U142684167 (to A.G.) at the Harwell Institute, and the Agence Nationale de la Recherche Grant ANR-10-LABX-73 (to K.M.). S.N. acknowledges support from Swiss National Science Foundation Grant 31003A_173070. M.S. was a visiting scientist supported by the Strategic International Research Exchange Program between Princeton University and National Institutes of Natural Sciences, Japan. D.T.G. was supported by National Institute of Arthritis and Mucoskeletal and Skin Diseases Pathway to Independence Award 1K99AR070905. Work in the R.D.B. laboratory is supported by the National Institute of Child Health and Development Grant 2R01HD048584., We thank the husbandry team in Ward 5 of the Mary Lyon Centre at Harwell and the Frozen Embryo and Sperm Archive (FESA) and histology teams. We thank Dagmar Wilhelm for the kind gift of anti-FOXL2 antibody. We thank Phil Johnson for zebrafish husbandry. We acknowledge European Cooperation in Science & Technology (COST) Action BM1303 (DSDnet)., ANR-10-LABX-0073,REVIVE,Stem Cells in Regenerative Biology and Medicine(2010), Université de Genève (UNIGE), Génétique du développement humain, Institut Pasteur [Paris], and Hubrecht Institute for Developmental Biology and Stem Cell Research
- Subjects
0301 basic medicine ,Male ,Embryo, Nonmammalian ,Sex Differentiation ,Organogenesis ,Wnt Proteins/antagonists & inhibitors ,Disorders of Sex Development ,DSD ,MESH: Wnt Proteins / metabolism ,MESH: Testis / metabolism ,MESH: Disorders of Sex Development / genetics ,MESH: Testis / pathology ,MESH: Embryo, Nonmammalian / cytology ,Mice ,Embryo, Nonmammalian/cytology ,MESH: Gene Expression Regulation, Developmental ,Testis ,Missense mutation ,MESH: Animals ,ddc:576.5 ,Developmental ,Disorders of sex development ,10. No inequality ,MESH: Ubiquitin-Protein Ligases / genetics ,Exome sequencing ,Cells, Cultured ,beta Catenin ,Zebrafish ,Multidisciplinary ,Cultured ,MESH: Thrombospondins / genetics ,MESH: SOX9 Transcription Factor / metabolism ,Wnt signaling pathway ,Gene Expression Regulation, Developmental ,SOX9 Transcription Factor ,beta Catenin/antagonists & inhibitors ,MESH: beta Catenin / metabolism ,Sex reversal ,MESH: Gonads / pathology ,Cell biology ,MESH: Young Adult ,Embryo ,MESH: Gonads / metabolism ,Female ,MESH: Cells, Cultured ,Adult ,Adolescent ,Ubiquitin-Protein Ligases ,Cells ,Thrombospondins/genetics ,Mutation, Missense ,MESH: beta Catenin / antagonists & inhibitors ,SOX9 ,Biology ,Gonads/metabolism ,MESH: Embryo, Nonmammalian / metabolism ,03 medical and health sciences ,Young Adult ,MESH: Wnt Proteins / genetics ,WNT signaling ,medicine ,Animals ,Humans ,Ubiquitin-Protein Ligases/genetics ,MESH: SOX9 Transcription Factor / genetics ,MESH: Zebrafish ,RSPO1 ,Gonads ,General ,MESH: Mice ,Nonmammalian/cytology ,MESH: Disorders of Sex Development / pathology ,MESH: Adolescent ,MESH: Wnt Proteins / antagonists & inhibitors ,MESH: Mutation, Missense ,MESH: Humans ,MESH: beta Catenin / genetics ,ZNRF3 ,MESH: Adult ,Sex determination ,medicine.disease ,MESH: Male ,MESH: Ubiquitin-Protein Ligases / physiology ,SOX9 Transcription Factor/genetics ,Wnt Proteins ,030104 developmental biology ,MESH: Thrombospondins / metabolism ,[SDV.GEN.GH]Life Sciences [q-bio]/Genetics/Human genetics ,Gene Expression Regulation ,Mutation ,Testis/metabolism ,Missense ,Thrombospondins ,MESH: Female ,Function (biology) ,Disorders of Sex Development/genetics ,MESH: Sex Differentiation - Abstract
International audience; Mammalian sex determination is controlled by the antagonistic interactions of two genetic pathways: The SRY-SOX9-FGF9 network promotes testis determination partly by opposing proovarian pathways, while RSPO1/WNT-β-catenin/FOXL2 signals control ovary development by inhibiting SRY-SOX9-FGF9. The molecular basis of this mutual antagonism is unclear. Here we show that ZNRF3, a WNT signaling antagonist and direct target of RSPO1-mediated inhibition, is required for sex determination in mice. XY mice lacking ZNRF3 exhibit complete or partial gonadal sex reversal, or related defects. These abnormalities are associated with ectopic WNT/β-catenin activity and reduced Sox9 expression during fetal sex determination. Using exome sequencing of individuals with 46,XY disorders of sex development, we identified three human ZNRF3 variants in very rare cases of XY female presentation. We tested two missense variants and show that these disrupt ZNRF3 activity in both human cell lines and zebrafish embryo assays. Our data identify a testis-determining function for ZNRF3 and indicate a mechanism of direct molecular interaction between two mutually antagonistic organogenetic pathways.
- Published
- 2018
45. High-throughput mouse phenomics for characterizing mammalian gene function
- Author
-
Damian Smedley, Sara Wells, Terrence F. Meehan, Christopher Holmes, Ann-Marie Mallon, and Steve D.M. Brown
- Subjects
0301 basic medicine ,Genome ,Genetic Variation ,Genomics ,Human genetic variation ,Computational biology ,Biology ,Phenome ,Article ,Mice ,03 medical and health sciences ,030104 developmental biology ,Phenomics ,Databases, Genetic ,Genetics ,Animals ,Humans ,Mammalian gene ,Molecular Biology ,Functional genomics ,Gene ,Genetics (clinical) ,Function (biology) ,Gene knockout - Abstract
We are entering a new era of mouse phenomics, driven by large-scale and economical generation of mouse mutants coupled with increasingly sophisticated and comprehensive phenotyping. These studies are generating large, multidimensional gene–phenotype data sets, which are shedding new light on the mammalian genome landscape and revealing many hitherto unknown features of mammalian gene function. Moreover, these phenome resources provide a wealth of disease models and can be integrated with human genomics data as a powerful approach for the interpretation of human genetic variation and its relationship to disease. In the future, the development of novel phenotyping platforms allied to improved computational approaches, including machine learning, for the analysis of phenotype data will continue to enhance our ability to develop a comprehensive and powerful model of mammalian gene–phenotype space. Although the field of functional genomics is increasingly adopting genome-scale approaches, a comprehensive understanding of gene functions requires the parallel development of deep phenotyping platforms. This Review discusses strategies for broad-based mouse phenomics, applied both to gene knockout collections and to diverse strains harbouring natural genetic variation. The authors discuss technical challenges, analysis pipelines and insights into human disease genetics.
- Published
- 2018
46. Assessing mouse behaviour throughout the light/dark cycle using automated in-cage analysis tools
- Author
-
Patrick M. Nolan, Heather Cater, J. Douglas Armstrong, Rowland R. Sillito, Rasneer Sonia Bains, Sara Wells, and Gareth Banks
- Subjects
0301 basic medicine ,Photoperiod ,Period (gene) ,Welfare ,Computational biology ,Biology ,Animal Welfare ,GeneralLiterature_MISCELLANEOUS ,Article ,Running ,Mice ,03 medical and health sciences ,0302 clinical medicine ,Animals ,Mouse Inbred Strains ,Circadian rhythm ,Motor function ,ComputingMethodologies_COMPUTERGRAPHICS ,Communication ,Behavior, Animal ,business.industry ,General Neuroscience ,Dark cycle ,Circadian ,Robustness (evolution) ,Wheel running ,Refinement ,Housing, Animal ,Circadian Rhythm ,030104 developmental biology ,Home cage ,Analysis tools ,business ,Cage ,030217 neurology & neurosurgery ,Behavioral Research - Abstract
Highlights • Automated assessment of mouse home-cage behaviour is robust and reliable. • Analysis over multiple light/dark cycles improves ability to classify behaviours. • Combined RFID and video analysis enables home-cage analysis in group housed animals., An important factor in reducing variability in mouse test outcomes has been to develop assays that can be used for continuous automated home cage assessment. Our experience has shown that this has been most evidenced in long-term assessment of wheel-running activity in mice. Historically, wheel-running in mice and other rodents have been used as a robust assay to determine, with precision, the inherent period of circadian rhythms in mice. Furthermore, this assay has been instrumental in dissecting the molecular genetic basis of mammalian circadian rhythms. In teasing out the elements of this test that have determined its robustness – automated assessment of an unforced behaviour in the home cage over long time intervals – we and others have been investigating whether similar test apparatus could be used to accurately discriminate differences in distinct behavioural parameters in mice. Firstly, using these systems, we explored behaviours in a number of mouse inbred strains to determine whether we could extract biologically meaningful differences. Secondly, we tested a number of relevant mutant lines to determine how discriminative these parameters were. Our findings show that, when compared to conventional out-of-cage phenotyping, a far deeper understanding of mouse mutant phenotype can be established by monitoring behaviour in the home cage over one or more light:dark cycles.
- Published
- 2018
47. When all is not lost: considering genetic compensation in laboratory animals
- Author
-
Rosie K. A. Bunton-Stasyshyn, Lydia Teboul, and Sara Wells
- Subjects
Genetics ,0303 health sciences ,General Veterinary ,040301 veterinary sciences ,Compensation (psychology) ,04 agricultural and veterinary sciences ,Biology ,0403 veterinary science ,03 medical and health sciences ,Expression (architecture) ,Mutation (genetic algorithm) ,Animal Science and Zoology ,Gene ,030304 developmental biology - Abstract
A recent article by El-Brolosy and colleagues introduced an unexpected twist for our understanding of knock-out mutations by revealing compensatory mechanisms that recruit the expression of other genes to mitigate the consequences of the mutation. We discuss the main findings of the paper and their impact for our interpretations of the effects of mutations in laboratory animals and humans.
- Published
- 2019
48. N-ethyl-N-nitrosourea-Induced Adaptor Protein 2 Sigma Subunit 1 (Ap2s1) Mutations EstablishAp2s1Loss-of-Function Mice
- Author
-
Roger D. Cox, Sara Wells, Lydia Teboul, Steve D.M. Brown, Rajesh V. Thakker, Michelle Stewart, Tertius Hough, Caroline M Gorvin, Angela Rogers, and Anju Paudyal
- Subjects
0301 basic medicine ,medicine.medical_specialty ,Familial hypocalciuric hypercalcemia ,Endocrinology, Diabetes and Metabolism ,Mutant ,Parathyroid hormone ,Signal transducing adaptor protein ,chemistry.chemical_element ,030209 endocrinology & metabolism ,Mutagen ,Biology ,Calcium ,medicine.disease_cause ,medicine.disease ,Molecular biology ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,Endocrinology ,chemistry ,Internal medicine ,medicine ,Alkaline phosphatase ,Orthopedics and Sports Medicine ,Receptor - Abstract
The adaptor protein-2 sigma subunit (AP2σ), encoded by AP2S1, forms a heterotetrameric complex, with AP2α, AP2β, and AP2μ subunits, that is pivotal for clathrin-mediated endocytosis, and AP2σ loss-of-function mutations impair internalization of the calcium-sensing receptor (CaSR), a G-protein-coupled receptor, and cause familial hypocalciuric hypercalcemia type-3 (FHH3). Mice with AP2σ mutations that would facilitate investigations of the in vivo role of AP2σ, are not available, and we therefore embarked on establishing such mice. We screened >10,000 mice treated with the mutagen N-ethyl-N-nitrosourea (ENU) for Ap2s1 mutations and identified 5 Ap2s1 variants, comprising 2 missense (Tyr20Asn and Ile123Asn) and 3 intronic base substitutions, one of which altered the invariant donor splice site dinucleotide gt to gc. Three-dimensional modeling and cellular expression of the missense Ap2s1 variants did not reveal them to alter AP2σ structure or CaSR-mediated signaling, but investigation of the donor splice site variant revealed it to result in an in-frame deletion of 17 evolutionarily conserved amino acids (del17) that formed part of the AP2σ α1-helix, α1-β3 loop, and β3 strand. Heterozygous mutant mice (Ap2s1+/del17 ) were therefore established, and these had AP2σ haplosufficiency but were viable with normal appearance and growth. Ap2s1+/del17 mice, when compared with Ap2s1+/+ mice, also had normal plasma concentrations of calcium, phosphate, magnesium, creatinine, urea, sodium, potassium, and alkaline phosphatase activity; normal urinary fractional excretion of calcium, phosphate, sodium, and potassium; and normal plasma parathyroid hormone (PTH) and 1,25-dihydroxyvitamin D (1,25(OH)2) concentrations. However, homozygous Ap2s1del17/del17 mice were non-viable and died between embryonic days 3.5 and 9.5 (E3.5-9.5), thereby indicating that AP2σ likely has important roles at the embryonic patterning stages and organogenesis of the heart, thyroid, liver, gut, lungs, pancreas, and neural systems. Thus, our studies have established a mutant mouse model that is haplosufficient for AP2σ.
- Published
- 2017
49. Exploring sense of community in adult recreational tennis
- Author
-
Preston Tanner, Eric Legg, Aubrey Newland, and Mary Sara Wells
- Subjects
Cultural Studies ,Social Psychology ,business.industry ,05 social sciences ,Sense of community ,Social benefits ,030229 sport sciences ,Public relations ,League ,Profit (economics) ,03 medical and health sciences ,0302 clinical medicine ,Tourism, Leisure and Hospitality Management ,0502 economics and business ,Recreational sports ,business ,Psychology ,Sport management ,human activities ,Recreation ,Amateur ,050212 sport, leisure & tourism - Abstract
Social benefits are of primary importance for adults involved in amateur recreational sports. Further, Chalip [(2006). Toward a distinctive sport management discipline. Journal Of Sport Management, 20(1), 1] recently identified social benefits as essential to the rationale of public delivery of sport programmes. Despite the clear importance of these benefits, limited research exists that seeks to understand how adult participants perceive their experience, if they experience social benefits, and how management practices can enhance such benefits. This research attempts to fill that gap by exploring the experience of participants in an adult recreational tennis league. Adult recreational tennis is particularly relevant to the field of leisure management as it represents a sport that may be played across the lifespan, and because delivery resides within public and private (commercial or not-for profit spheres). We interviewed 21 intermediate players in adult recreational leagues to investigate their...
- Published
- 2017
50. Application of long-read sequencing for robust identification of correct alleles in genome edited animals
- Author
-
Alasdair J Allan, Marie Hutchison, Jorik Loeffler, Christou S, Sara Wells, Matthew Mackenzie, Michelle Stewart, Pike Fj, Adam Caulder, Malzer E, Lydia Teboul, Nicholas D Sanderson, Joffrey Mianné, McCabe Cv, Gemma F. Codner, and Gates H
- Subjects
0303 health sciences ,Cas9 ,Locus (genetics) ,Computational biology ,Biology ,Genome ,03 medical and health sciences ,0302 clinical medicine ,Genome editing ,Homologous chromosome ,CRISPR ,Nanopore sequencing ,Allele ,030217 neurology & neurosurgery ,030304 developmental biology - Abstract
Recent developments in CRISPR/Cas9 genome editing tools have facilitated the introduction of more complex alleles, often spanning genetic intervals of several kilobases, directly into the embryo. These techniques often produce mosaic founder animals and the introduction of donor templates, via homologous directed repair, can be erroneous or incomplete. Newly generated alleles must be verified at the sequence level across the targeted locus. Screening for the presence of the desired mutant allele using traditional sequencing methods can be challenging due to the size of the desired edit(s) together with founder mosaicism. In order to help disentangle the genetic complexity of these animals, we tested the application of Oxford Nanopore long read sequencing of the targeted locus. Taking advantage of sequencing the entire length of the segment in each single read, we were able to determine whether the entire intended mutant sequence was present in both mosaic founders and their offspring.
- Published
- 2019
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.